Clinical Payment Policies | Ambetter from Arkansas Health & Wellness

 

Clinical & Payment Policies

To easily search for a policy, use the Ctrl+F (Command+F on Mac) function on your keyboard to search by keyword, policy number or effective date.

What are Clinical Policies?

Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include policies relating to evolving medical technologies and procedures as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice, including peer-reviewed medical literature, government agency/program approval status, evidence-based guidelines, positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas affected by the policy, and other available clinical information. 

All policies found in the Arkansas Health & Wellness Clinical Policy Manual apply to Arkansas Health & Wellness members. Policies in the Arkansas Health & Wellness Clinical Policy Manual may have either an “Arkansas Health & Wellness” or a “Centene” heading.  Arkansas Health & Wellness utilizes InterQual® criteria for those medical technologies, procedures, or pharmaceutical treatments for which an Arkansas Health & Wellness clinical policy does not exist. InterQual is a nationally recognized evidence-based decision support tool. You may access the InterQual SmartSheets™ for adult and pediatric procedures, durable medical equipment, and imaging procedures by logging in to our Secure Provider Portal or calling Arkansas Health & Wellness at 1-877-617-0390 (TTY 1-877-617-0392).

Arkansas Health & Wellness may, from time to time, delegate utilization management of specific services. In such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in the Clinical Policy Manuals or InterQual criteria is payable by Arkansas Health & Wellness.

What are Payment Policies?

Healthcare claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether healthcare services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include claims processing guidelines referenced by the Centers for Medicare & Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), CPT® guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of healthcare and medical necessity, and, at times, state-specific claims reimbursement
guidance.

All policies found in the Arkansas Health & Wellness Payment Policy Manual apply with respect to Arkansas Health & Wellness members. Policies in the Arkansas Health & Wellness Payment Policy Manual may have either an “Arkansas Health & Wellness” or a “Centene” heading. Arkansas Health & Wellness may, from time-to-time, employ a vendor that applies payment policies to specific services. In such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in the Payment Policy Manual is payable by Arkansas Health & Wellness. 

Prior Authorization Requests

Ambetter from Arkansas Health and Wellness will be partnering with Evolent for prior authorization requests for the following services:

  • Physical Therapy
  • Occupational Therapy
  • Speech Therapy
  • Spinal Epidural Injections
  • Paravertebral Facet Joint Injections or Blocks
  • Paravertebral Facet Joint Denervation (Radiofrequency Neurolysis)
  • Sacroiliac Joint Injections

Clinical Policies for these procedures can be found at the http://www.radmd.com/.

Clinical Policies for CT/CTA/CCTA, MRI, MRA, and Pet Scans can also be found at the http://www.radmd.com/.

Clinical policies for musculoskeletal procedures can be found on the Turning point website at http://www.myturningpoint-healthcare.com/

Prior Authorization statistics may be viewed here.

Policy TitlePolicy NumberEffective Date
25-hydroxyvitamin D Testing in Children and Adolescents (PDF)CP.MP.157November 1, 2024
Air Ambulance (PDF)CP.MP.175May 1, 2025
Allergy Testing and Therapy (PDF)CP.MP.100November 1, 2024
Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (PDF)CP.MP.108October 1, 2025
Allogeneic Hematopoietic Progenitor Cell Therapy (PDF)CP.MP.249October 1, 2025
Applied Behavior Analysis (PDF)CP.BH.104February 1, 2026
Applied Behavioral Analysis Documentation Requirements (PDF)CP.BH.105June 1, 2025
Arkansas Medical Audit Bill of Rights Act Policy (PDF)AR.BO.04August 5, 2025
Assisted Reproductive Technology (PDF)CP.MP.55July 1, 2025
Attention Deficit Hyperactivity Disorder and Treatment (PDF)CP.BH.124December 1, 2024
Bariatric Surgery (PDF)AR.CP.MP.37
January 1, 2026
Behavioral Health Treatment Documentation Requirements (PDF)HIM.CP.BH.500August 1, 2025
Biofeedback (PDF)CP.MP.168February 1, 2025
Biofeedback for Behavioral Health Disorders (PDF)CP.BH.300January 1, 2025
Bone-Anchored Hearing Aids (PDF)AR.CP.MP.93January 1, 2025
Burn Surgery (PDF)CP.MP.186January 15, 2026
Cardiac Biomarker Testing (PDF)CP.MP.156November 1, 2024
Caudal or Interlaminar Epidural Steroid Injections (PDF)CP.MP.164July 1, 2025
Clinical Trials (PDF)CP.MP.94August 1, 2025
Cochlear Implanted Replacements (PDF)AR.CP.MP.14July 1, 2025
Concert Genetics Oncology: Algorithmic Testing (PDF)V1.2025April 1, 2025
Concert Genetics Oncology: Cancer Screening (PDF)AR.HIM.V1.2025
April 1, 2025
Concert Genetics Oncology: Circulating Tumor DNA and Circulating
Tumor Cells (Liquid Biopsy) (PDF)
V1.2025
April 1, 2025
Concert Genetics Oncology: Cytogenetic Testing (PDF)V1.2025
April 1, 2025
Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Aortopathies and Connective Tissue Disorders (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Cardiac Disorders (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Dermatologic Conditions (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular Disorders (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Eye Disorders (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Gastroenterologic Disorders (non-cancerous) (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: General Approach to Genetic and Molecular Testing (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Hearing Loss (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Hematologic Conditions (non-cancerous) (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Hereditary Cancer Susceptibility (PDF)V1.2025March 1, 2025
Concert Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Kidney Disorders (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Lung Disorders (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Pharmacogenetics (Version B) (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Preimplantation Genetic Testing (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Prenatal and Preconception Carrier Screening (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Prenatal Cell-Free DNA Testing (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF)V1.2025
April 1, 2025
Concert Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF)V1.2025
April 1, 2025
Cosmetic and Reconstructive Procedures (PDF)AR.CP.MP.31January 1, 2026
Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder (PDF)CP.BH.201July 1, 2025
Diaphragmatic/Phrenic Nerve Stimulation (PDF)CP.MP.203September 1, 2024
Digital EEG Spike Analysis (PDF)CP.MP.105November 1, 2024
Disc Decompression Procedures (PDF)CP.MP.114June 1, 2025
Discography (PDF)CP.MP.115June 1, 2025
Donor Lymphocyte Infusion (PDF)CP.MP.101April 1, 2025
Drugs of Abuse: Definitive Testing (PDF)CP.MP.50November 1, 2024
Durable Medical Equipment and Orthotics and Prosthetics Guidelines (PDF)CP.MP.107January 1, 2026
EEG in the Evaluation of Headache (PDF)CP.MP.155November 1, 2024
Electric Tumor Treating Fields (Optune) (PDF)CP.MP.145December 15, 2025
Endometrial Ablation (PDF)CP.MP.106April 1, 2025
Evoked Potential Testing (PDF)CP.MP.134November 1, 2024
Experimental Technologies (PDF)CP.MP.36October 1, 2025
Facet Joint Interventions (PDF)CP.MP.171July 1, 2025
Facility-based Sleep Studies for Obstructive Sleep Apnea (PDF)CP.MP.248March 1, 2025
Fecal Incontinence Treatments (PDF)CP.MP.137October 1, 2025
Fetal Surgery in Utero for Prenatally Diagnosed Malformations (PDF)CP.MP.129July 1, 2025
Fertility Preservation (PDF)CP.MP.130March 1, 2025
Gastric Electrical Stimulation (PDF)CP.MP.40June 1, 2025
Gender-Affirming Procedures (PDF)CP.MP.95
September 1, 2024
Heart-Lung Transplant (PDF)CP.MP.132September 1, 2025
Helicobacter Pylori Serology Testing (PDF)CP.MP.153November 1, 2024
Holter Monitors (PDF)CP.MP.113May 1, 2025
Home Births (PDF)CP.MP.136June 1, 2025
Home Ventilators (PDF)AR.CP.MP.184August 1, 2025
Hospice Services (PDF)CP.MP.54August 1, 2025
Hyperhidrosis Treatments (PDF)CP.MP.62January 15, 2026
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (PDF)CP.MP.180August 1, 2025
Implantable Intrathecal or Epidural Pain Pump (PDF)CP.MP.173January 15, 2026
Implantable Loop Recorder (PDF)CP.MP.243January 15, 2026
Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF)CP.MP.160April 1, 2025
Intensity-Modulated Radiotherapy (PDF)CP.MP.69July 1, 2025
Intestinal and Multivisceral Transplant (PDF)CP.MP.58September 1, 2025
Intradiscal Steroid Injections for Pain Management (PDF)CP.MP.167September 1, 2024
IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (PDF)CP.MP.61February 1, 2026
Lantidra (donislecel): Allogeneic Pancreatic Islet Cellular Therapy (PDF)CP.MP.250September 1, 2024
Laser Therapy for Skin Conditions (PDF)CP.MP.123November 1, 2024
Liposuction for Lipedema (PDF)CP.MP.244June 1, 2025
Lung Transplantation (PDF)CP.MP.57July 1, 2025
Lysis of Epidural Lesions (PDF)CP.MP.116June 1, 2025
Mechanical Stretching Devices for Joint Stiffness and Contracture (PDF)CP.MP.144December 15, 2025
Measurement of Serum 1.25-dihydroxyvitamin D (PDF)CP.MP.152November 1, 2024
Multiple Sleep Latency TestingCP.MP.24September 1, 2025
Neonatal Abstinence Syndrome Guidelines (PDF)CP.MP.86August 1, 2025
Neonatal Sepsis Management (PDF)CP.MP.85August 1, 2025
Nerve Blocks and Neurolysis for Pain Management (PDF)CP.MP.170April 1, 2025
Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (PDF)CP.MP.48July 1, 2025
NICU Apnea Bradycardia Guidelines (PDF)CP.MP.82August 1, 2025
NICU Discharge Guidelines (PDF)CP.MP.81August 1, 2025
Nonmyeloablative Allogeneic Stem Cell Transplants (PDF)CP.MP.141March 1, 2025
Obstetrical Home Care Programs (PDF)CP.MP.91February 1, 2025
Orthognathic Surgery (PDF)CP.MP.202 January 15, 2026
Osteogenic Stimulation (PDF)CP.MP.194August 1, 2025
Outpatient Acquired Brain Injury Services (PDF)AR.CP.MP.501January 1, 2026
Outpatient Cardiac Rehabilitation (PDF)CP.MP.176July 1, 2025
Outpatient Oxygen Use (PDF)CP.MP.190February 1, 2025
Pancreas Transplantation (PDF)CP.MP.102June 1, 2025
Panniculectomy (PDF)CP.MP.109October 1, 2025
Pediatric Heart Transplant (PDF)CP.MP.138October 1, 2025
Pediatric Kidney Transplant (PDF)CP.MP.246April 1, 2025
Pediatric Liver Transplant (PDF)CP.MP.120July 1, 2025
Pediatric Oral Function Therapy (PDF)CP.MP.188June 1, 2025
Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (PDF)CP.MP.147August 1, 2025
Phototherapy for Neonatal Hyperbilirubinemia (PDF)CP.MP.150August 1, 2025
Physical, Occupational, and Speech Therapy Services (PDF)CP.MP.49November 1, 2025
Polymerase Chain Reaction Respiratory Viral Panel Testing (PDF)CP.MP.181November 1, 2024
Posterior Tibial Nerve Stimulation for Voiding Dysfunction (PDF)CP.MP.133September 1, 2024
Proton and Neutron Beam Therapies (PDF)CP.MP.70January 15, 2026
Pulmonary Function Testing (PDF)CP.MP.242November 1, 2024
Radiation Therapy for Skin Cancer (PDF)CP.MP.251 October 1, 2025
Reduction Mammoplasty and Gynecomastia Surgery (PDF)CP.MP.51October 1, 2025
Repair of Nasal Valve Compromise (PDF)CP.MP.210June 1, 2025
Sacroiliac Joint Fusion (PDF)CP.MP.126June 1, 2025
Sacroiliac Joint Interventions for Pain Management (PDF)CP.MP.166December 1, 2025
Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (PDF)CP.MP.146May 1, 2025
Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy (PDF)CP.MP.174February 1, 2025
Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (PDF)CP.MP.165December 1, 2025
Short Inpatient Hospital Stay (PDF)CP.MP.182 May 15, 2025
Skin and Soft Tissue Substitutes for Chronic Wounds (PDF)CP.MP.185November 1, 2025
Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (PDF)CP.MP.117February 1, 2025
Stereotactic Body Radiation Therapy (PDF)CP.MP.22December 15, 2025
Tandem Transplant (PDF)CP.MP.162June 1, 2025
Testing for Select Geniroutinary Conditions (PDF)CP.MP.97May 1, 2025
Therapeutic Utilization of Inhaled Nitric Oxide (PDF)CP.MP.87September 1, 2025
Thyroid Hormones and Insulin Testing in Pediatrics (PDF)CP.MP.154November 1, 2024
Total Artificial Heart (PDF)CP.MP.127October 1, 2025
Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF)CP.MP.163April 1, 2025
Transplant Service Documentation Requirements (PDF)CP.MP.247September 1, 2025
Transcranial Magnetic Stimulation for Treatment Resistant Major Depression (PDF)CP.BH.200July 1, 2025
Trigger Point Injections for Pain Management (PDF)CP.MP.169September 1, 2025
Ultrasound in Pregnancy (PDF)CP.MP.38November 1, 2024
Urinary Incontinence Devices and Treatments (PDF)CP.MP.142January 15, 2026
Urodynamic Testing (PDF)CP.MP.98November 1, 2024
Vagus Nerve Stimulation (PDF)CP.MP.12September 1, 2025
Ventricular Assist Devices (PDF)CP.MP.46January 15, 2026
Wheelchair Seating (PDF)CP.MP.99November 1, 2024
Wireless Mobility Capsule (PDF)CP.MP.143November 1, 2024

Policy TitlePolicy NumberEffective Date
25-hydroxyvitamin D Testing in Children and Adolescents (PDF)CP.MP.157 November 1, 2024
3-Day Payment Window (PDF)CC.PP.500July 1, 2014
30 Day Readmission (PDF)CP.PP.501May 15, 2025
Add-On Code Billed Without Primary Code (PDF)CC.PP.030October 18, 2016
Allergy Testing and Therapy (PDF)CP.MP.100November 1, 2024
Ambulatory EEG (PDF)CP.MP.96August 12, 2016
Assistant Surgeon (PDF)CC.PP.029February 7, 2017
Attention Deficit Hyperactivity Disorder Assessment and Treatment (PDF)CP.BH.124December 1, 2024
Bilateral Procedures (PDF)CC.PP.037February 7, 2017
Cardiac Biomarker Testing (PDF)CP.MP.156 November 1, 2024
Cerumen Removal (PDF)CC.PP.008August 12, 2016
Clean Claims (PDF)CC.PP.021October 18, 2016
Coding Overview (PDF)CC.PP.011October 18, 2016
Cosmetic Procedures (PDF)CC.PP.024October 18, 2016
Digital EEG Spike Analysis (PDF)CP.MP.105November 1, 2024
Distinct Procedural Modifiers (PDF)CC.PP.020October 18, 2016
Drugs of Abuse: Definitive Testing (PDF)CP.MP.50 November 1, 2024
Duplicate Primary Code Billing (PDF)CC.PP.044February 7, 2017
EEG in the Evaluation of Headache (PDF)CP.MP.155November 1, 2024
E&M Medical Decision-Making (PDF)CC.PP.051July 25, 2017
EM Bundling Edits (PDF)CC.PP.010August 12, 2016
Endometrial Ablasion (PDF)CP.MP.106April 1, 2025
Evoked Potential Testing (PDF)CP.MP.134November 1, 2024
Genetic and Molecular Testing Services (Version C)CG.PP.551November 1, 2025
Global Maternity Billing (PDF)CC.PP.016October 18, 2016
Helicobacter Pylori Serology Testing (PDF)CP.MP.153November 1, 2024
Holter Monitors (PDF)CP.MP.113May 1, 2025
Hospital Visit Codes Billed with Labs (PDF)CC.PP.023October 18, 2016
Inpatient Consultation (PDF)CC.PP.038February 7, 2017
Inpatient Only Procedures (PDF)MP.PP.018April 1, 2024
IV Hydration (PDF)CC.PP.012October 18, 2016
Laser Therapy for Skin Conditions (PDF)CP.MP.123November 1, 2024
Leveling of Care: Emergency Department Evaluation and Management Overcoding for Professional Services (PDF)CC.PP.076May 1, 2026
Leveling of Care: Evaluation and Management Overcoding (PDF)CC.PP.066March 15, 2021
Leveling of Emergency Room (PDF)CC.PP.053 January 1, 2019
Maximum Units (PDF)CC.PP.007August 12, 2016
Measurement of Serum 1,25-dihydroxyvitamin D (PDF)CP.MP.152November 1, 2024
Moderate Conscious Sedation (PDF)CC.PP.015October 18, 2016
Modifier -25 clinical validation (PDF)CC.PP.013October 18, 2016
Modifier -59 clinical validation (PDF)CC.PP.014October 18, 2016
Modifier DOS Validation (PDF)CC.PP.034October 18, 2016
Modifier to Procedure Code Validation (PDF)CC.PP.028October 18, 2016
Multiple CPT Code Replacement (PDF)CC.PP.033October 18, 2016
Multiple Diagnostic Cardiovascular Procedure Payment Reduction (PDF)CC.PP.065March 15, 2021
Multiple Procedure Reduction: Ophthalmology (PDF)CC.PP.069March 15, 2021
Multiple Procedure Payment Reduction for Therapeutic Services (PDF)CC.PP.068March 15, 2021
NCCI Unbundling (PDF)CC.PP.031October 18, 2016
Never Paid Events (PDF)CC.PP.017October 18, 2016
Newborn Inpatient Stays (PDF)CC.PP.075January 1, 2026
Non-Obstetrical Pelvic and Transabdominal Ultrasound (PDF)CC.PP.061 March 15, 2021
Outpatient Consultation (PDF)CC.PP.039February 7, 2017
Physician’s Consultation Services (PDF)CC.PP.054September 1, 2018
Physician Visit Codes Billed with Labs (PDF)CC.PP.019October 18, 2016
Place of Service Mismatch (PDF)CC.PP.063 December 15, 2018
Polymerase Chain Reaction Respiratory Viral Panel Testing (PDF)CP.MP.181 November 1, 2024
Post-Operative Visits (PDF)CC.PP.042February 7, 2017
Pre-Operative Visits (PDF)CC.PP.041February 7, 2017
Problem Oriented Visits with Preventative Services (PDF)CC.PP.057November 1, 2018
Problem Oriented Visits with Surgical Procedures (PDF)CC.PP.052November 1, 2018
Professional Component (PDF)CC.PP.027October 18, 2016
Pulmonary Function Testing (PDF)CP.MP.242November 1, 2024
Pulse Oximetry (PDF)CC.PP.025October 18, 2016
Renal Hemodialysis (PDF)CC.PP.067March 15, 2021
Robotic Surgery (PDF)CC.PP.050November 1, 2017
Same Day Visits (PDF)CC.PP.040February 7, 2017
Sepsis Diagnosis (PDF)CC.PP.073 November 1, 2024
Skilled Nursing Facility Leveling (PDF)CC.PP.206May 1, 2025
Status "B" Bundled Services (PDF)CC.PP.046February 7, 2017
Status P Bundled Services (PDF)CC.PP.049June 17, 2017
Supplies Billed on Same Day As Surgery (PDF)CC.PP.032October 18, 2016
Testing for Select Genitourinary Conditions (PDF)CP.MP.97May 1, 2025
Thyroid Hormones and Insulin Testing in Pediatrics (PDF)CP.MP.154November 1, 2024
Transgender Related Services (PDF)CC.PP.047February 22, 2017
Ultrasound in Pregnancy (PDF)CP.MP.38November 1, 2024
Unbundled Professional Services (PDF)CC.PP.043April 6, 2017
Unbundled Surgical Procedures (PDF)CC.PP.045April 6, 2017
Unlisted Procedure Codes (PDF)CC.PP.009August 12, 2016
Urine Specimen Validity Testing (PDF)CC.PP.056November 8, 2017
Urodynamic Testing (PDF)CP.MP.98November 1, 2024
Wheelchair Accessories (PDF)CC.PP.502August 12, 2016
Wheelchair Seating (PDF)CP.MP.99November 1, 2024
Wireless Motility Capsule (PDF)CP.MP.143November 1, 2024

Policy TitlePolicy NumberEffective Date
Abaloparatide (Tymlos) (PDF)CP.PHAR.345October 1, 2025
Abatacept (Orencia) (PDF)CP.PHAR.241July 1, 2024
Abemaciclib (Verzenio) (PDF)CP.PHAR.355March 1, 2026
Abemaciclib (Verzenio) (PDF)CP.PHAR.355Version effective until March 1, 2026
Abiraterone (Zytiga) (PDF)CP.PHAR.84April 1, 2025
AbobotulinumtoxinA (Dysport) (PDF)CP.PHAR.230October 1, 2025
Abrocitinib (Cibinqo) (PDF)CP.PCH.57March 1, 2026
Abrocitinib (Cibinqo) (PDF)CP.PHAR.578Retire by March 1, 2026
Acalabrutinib (Calquence) (PDF)CP.PHAR.366June 1, 2025
Aceclidine (Vizz) (PDF)CP.PMN.302March 1, 2026
Acoltremon (Tryptyr) (PDF)CP.PHAR.739October 1, 2025
Acoramidis (Attruby) (PDF)CP.PHAR.683October 1, 2025
Acyclovir Buccal tab (Sitavig) (PDF)CP.PMN.210December 1, 2025
Adagrasib (Krazati) (PDF)CP.PHAR.605October 1, 2025
ADAMTS13, recombinant-krhn (Adzynma) (PDF)CP.PHAR.635April 1, 2025
Adefovir (Hepsera) (PDF)CP.PHAR.142December 1, 2025
Ado-Trastuzumab Emtansine (Kadcyla) (PDF)CP.PHAR.229July 1, 2025
Aducanumab (Aduhelm) (PDF)CP.PHAR.468July 1, 2025
Afamelanotide (Scenesse) (PDF)CP.PHAR.444April 1, 2025
Afamitresgene Autoleucel (Tecelra) (PDF)CP.PHAR.678January 1, 2026
Afatinib (Gilotrif) (PDF)CP.PHAR.298July 1, 2025
Aflibercept (Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu) (PDF)CP.PHAR.184February 1, 2026
Aflibercept (Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu) (PDF)CP.PHAR.184Version effective until February 1, 2026
Agalsidase Beta (Fabrazyme) (PDF)CP.PHAR.158September 1, 2025
Agalsidase Beta (Fabrazyme) (PDF)CP.PHAR.158 September 1, 2025
Age Limit Override (PDF)HIM.PA.177January 1, 2026
Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF)CP.PMN.138October 1, 2025
Alectinib (Alecensa) (PDF)CP.PHAR.369July 1, 2025
Alemtuzumab (Lemtrada) (PDF)CP.PHAR.243July 1, 2025
Alendronate (Binosto, Fosamax plus D) (PDF)CP.PMN.88April 1, 2025
Alglucosidase (Lumizyme) (PDF)CP.PHAR.160April 1, 2025
Allogeneic cultured keratinocytes and dermal fibroblasts (StrataGraft) (PDF)CP.PHAR.562April 1, 2025
Allogenic processed thymus tissue-agdc (Rethymic) (PDF)CP.PHAR.563April 1, 2025
Alpelisib (Piqray) (PDF)CP.PHAR.430December 1, 2025
Alpha-1 Proteinase Inhibitors (Aralast® NP, Glassia®, Prolastin-C®, Zemaira®) (PDF)CP.PHAR.94April 1, 2025
Amantadine ER (Gocovri,Osmolex ER) (PDF)CP.PMN.89April 1, 2025
Ambrisentan (Letairis®) (PDF)CP.PHAR.190April 1, 2025
Amifampridine (Firdapse)(PDF)CP.PHAR.411April 1, 2025
Amikacin (Arikayce)(PDF) CP.PHAR.401October 1, 2025
Amisulpride (Barhemsys)(PDF)CP.PMN.236October 1, 2025
Amivantamab-vmjw (Rybrevant) (PDF)CP.PHAR.544December 1, 2025
Anifrolumab-fnia (Saphnelo) (PDF)CP.PHAR.551December 1, 2025
Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF)CP.PHAR.217April 1, 2025
Antithymocyte Globulin (Thymoglobulin, Atgam) (PDF)CP.PHAR.506December 1, 2025
Antithrombin III (ATryn, Thrombate III) (PDF)CP.PHAR.564April 1, 2025
Apalutamide (Erleada) (PDF)CP.PCH.45July 1, 2025
Apomorphine (Apokyn) (PDF)CP.PHAR.488October 1, 2025
Aprepitant (Emend®) (PDF)CP.PMN.19October 1, 2025
Aprocitentan (Tryvio) (PDF)CP.PHAR.676July 1, 2025
Arimoclomol (Miplyffa) (PDF)CP.PHAR.510March 1, 2026
Aripiprazole Long-Acting Injections (Abilify Maintena, Aristada) (PDF)CP.PHAR.290December 1, 2025
Aripiprazole ODT (Abilify) (PDF)CP.PMN.300April 1, 2025
Armodafinil (Nuvigil) (PDF)CP.PMN.35July 1, 2025
Asciminib (Scemblix) (PDF)CP.PHAR.565June 1, 2025
Asenapine (Saphris) (PDF)CP.PMN.15October 1, 2025
Asfotase Alfa (Strensiq) (PDF)CP.PHAR.328December 1, 2025
Aspirin-dipyridamole (Aggrenox) (PDF)CP.PMN.20April 1, 2025
Atezolizumab (Tecentriq) (PDF)CP.PHAR.235June 1, 2025
Atidarsagene autotemcel (Lenmeldy) (PDF)CP.PHAR.602January 1, 2026
Atogepant (Qulipta) (PDF)CP.PHAR.566December 1, 2025
Atrasentan (Vanrafia) (PDF)CP.PHAR.727July 1, 2025
Avacopan (Tavneos) (PDF)CP.PHAR.515April 1, 2025
Avacincaptad pegol (Izervay) (PDF)CP.PHAR.641December 1, 2025
Avalglucosidase alfa-ngpt (Nexviazyme) (PDF)CP.PHAR.521April 1, 2025
Avapritinib (Ayvakit) (PDF)CP.PHAR.454April 1, 2025
Avatrombopag (Doptelet) (PDF)CP.PHAR.130March 1, 2026
Avatrombopag (Doptelet) (PDF)CP.PHAR.130Version effective until March 1, 2026
Avelumab (Bavencio) (PDF)CP.PHAR.333April 1, 2025
Avutometinib, Defactinib (Avmapki Fakzynja Co-Pack) (PDF)CP.PHAR.731October 1, 2025
Axatilimab-csfr (Niktimvo) (PDF)CP.PHAR.691March 1, 2026
Axatilimab-csfr (Niktimvo) (PDF)CP.PHAR.691Version effective until March 1, 2026
axicabtagene ciloleucel (Yescarta®) (PDF)CP.PHAR.362January 1, 2026
Axitinib (Inlyta) (PDF)CP.PHAR.100April 1, 2025
Azacitidine (Vidaza) (PDF)CP.PHAR.387March 1, 2026
Azacitidine (Vidaza) (PDF)CP.PHAR.387Version effective until March 1, 2026
Azelaic Acid (Finacea) (PDF)HIM.PA.119December 1, 2025
Aztreonam (Cayston) (PDF)CP.PHAR.209October 1, 2025
Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF)CP.PHAR.149March 1, 2026
Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF)CP.PHAR.149Version effective until March 1, 2026
Baloxavir Marboxil (Xofluza) (PDF)CP.PMN.185December 1, 2025
Bamlanivimab-etesevimab (LY-CoV555-LY-CoV016) (PDF)CP.PHAR.532July 1, 2023
Bardoxolone Methyl (RTA 402) (PDF)CP.PHAR.560December 1, 2023
Bedaquiline (Sirturo) (PDF)CP.PMN.212February 1, 2026
Bedaquiline (Sirturo) (PDF)CP.PMN.212Version effective until February 1, 2026
Belatacept (Nulojix®) (PDF)CP.PHAR.201December 1, 2025
Belimumab (Benlysta) (PDF)CP.PHAR.88October 1, 2025
Belinostat (Beleodaq®) (PDF)CP.PHAR.311December 1, 2025
Bempedoic acid (Nexletol), bempedoic acid-ezetimibe (Nexlizet) (PDF)CP.PMN.237April 1, 2025
Bendamustine (Bendeka®, Treanda®) (PDF)CP.PHAR.307March 1, 2026
Bendamustine (Bendeka®, Treanda®) (PDF)CP.PHAR.307Version effective until March 1, 2026
Benralizumab (Fasenra) (PDF)HIM.PA.SP70January 1, 2026
Benralizumab (Fasenra) (PDF)CP.PHAR.373January 1, 2025
Benznidazole (PDF)CP.PMN.90April 1, 2025
Berdazimer (Zelsuvmi) (PDF)CP.PMN.293July 1, 2025
Beremagene Geperpavec (Vyjuvek) (PDF)CP.PHAR.592February 1, 2026
Beremagene Geperpavec (Vyjuvek) (PDF)CP.PHAR.592Version effective until February 1, 2026
Betaine (Cystadane) (PDF)CP.PHAR.143December 1, 2025
Betibeglogene autotemcel (PDF)CP.PHAR.545January 1, 2026
Bevacizumab (Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev) (PDF)CP.PHAR.93March 1, 2026
Bevacizumab (Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev) (PDF)CP.PHAR.93Version effective until March 1, 2026
Bexarotene (Targretin) (PDF)CP.PHAR.75July 1, 2025
Bezlotoxumab (Zinplava) (PDF)CP.PHAR.300April 1, 2025
Belantamab mafodotin (Blenrep) (PDF)CP.PHAR.469July 1, 2025
Belumosudil (Rezurock) (PDF)CP.PHAR.552March 1, 2026
Belumosudil (Rezurock) (PDF)CP.PHAR.552Version effective until March 1, 2026
Belzutifan (Welireg) (PDF)CP.PHAR.553December 1, 2025
Berotralstat (Orladeyo) (PDF)HIM.PA.169October 1, 2025
Betamethasone Dipropionate Spray (Sernivo) (PDF)CP.PMN.182December 1, 2025
Bimatoprost Implant (Durysta) (PDF)CP.PHAR.486October 1, 2025
Binimetinib (Mektovi) (PDF)CP.PHAR.50July 1, 2025
Biologic and Non-biologic DMARDs (PDF)HIM.PA.SP60March 1, 2026
Biologic and Non-biologic DMARDs (PDF)HIM.PA.SP60Version effective until March 1, 2026
Birch Triterpenes (Filsuvez) (PDF)CP.PHAR.669June 1, 2025
Blinatumomab (Blincyto) (PDF)CP.PHAR.312December 1, 2025
Bortezomib (Velcade) (PDF)CP.PHAR.410February 1, 2026
Bortezomib (Velcade) (PDF)CP.PHAR.410Version effective until February 1, 2026
Bosentan (Tracleer®) (PDF)CP.PHAR.191April 1, 2025
Bosutinib (Bosulif) (PDF)CP.PHAR.105July 1, 2025
Brand Name Override and Non-Formulary Medications (PDF)HIM.PA.103December 1, 2025
Brensocatib (Brinsupri) (PDF)CP.PMN.303March 1, 2026
Brentuximab Vedotin (Adcetris) (PDF)CP.PHAR.303December 1, 2025
Brexanolone (Zulresso) (PDF)CP.PHAR.417July 1, 2025
Brexpiprazole (Rexulti) (PDF)CP.PMN.68October 1, 2025
Brexucabtagene Autoleucel (Tecartus) (PDF)CP.PHAR.472January 1, 2026
Brigatinib (Alunbrig) (PDF)CP.PHAR.342July 1, 2025
Brivaracetam (Briviact) (PDF)CP.PMN.297December 1, 2025
Brolucizumab-dbll (Beovu) (PDF)CP.PHAR.445June 1, 2025
Brimonidine (Mirvaso) (PDF)CP.PMN.192October 1, 2025
Brinzolamide/Brimonidine (Simbrinza) (PDF)HIM.PA.15Retire by March 1, 2026
Brivaracetam (Briviact) (PDF)CP.PCH.26January 1, 2025
Budesonide (Eohilia, Uceris) (PDF)CP.PMN.294July 1, 2025
Budesonide (Tarpeyo) (PDF)CP.PHAR.572April 1, 2025
Buprenorphine/Naloxone (Bunavail, Cassipa, Suboxone, Zubsolv) (PDF)CP.PMN.81April 1, 2025
Buprenorphine (Subutex)CP.PMN.82April 1, 2025
Butorphanol Nasal Spray (PDF)HIM.PA.46July 1, 2025
C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF)HIM.PA.170October 1, 2025
Cabazitaxel (Jevtana) (PDF)CP.PHAR.316July 1, 2025
Cabotegravir, Cabotegravir-Rilpivirine (Apretude Cabenuva) (PDF)CP.PHAR.573April 1, 2025
Cabozantinib (Cometriq®, Cabometyx®) (PDF)CP.PHAR.111December 1, 2025
Calcifediol (Rayaldee) (PDF)CP.PMN.76October 1, 2025
Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF)CP.PMN.181December 1, 2025
Canakinumab (Ilaris) (PDF)CP.PHAR.246March 1, 2026
Canakinumab (Ilaris) (PDF)CP.PHAR.246Version effective until March 1, 2026
Cannabidiol (Epidiolex) (PDF)CP.PMN.164October 1, 2025
Capecitabine (Xeloda) (PDF)CP.PHAR.60July 1, 2025
Capivasertib (Truqap) (PDF)CP.PHAR.663April 1, 2025
Caplacizumab-yhdp (Cablivi) (PDF)CP.PHAR.416July 1, 2025
Capmatinib (Tabrecta) (PDF)CP.PHAR.494October 1, 2025
Carbetocin (PDF)CP.PHAR.546Pending FDA Approval
Carbidopa-Levodopa ER Capsules (Rytary), Enteral Suspension (Duopa) (PDF)CP.PMN.238October 1, 2025
Carfilzomib (Kyprolis®) (PDF)CP.PHAR.309March 1, 2026
Carfilzomib (Kyprolis®) (PDF)CP.PHAR.309Version effective until March 1, 2026
Carglumic acid (Carbaglu®) (PDF)CP.PHAR.206June 1, 2025
Cariprazine (Vraylar) (PDF)CP.PMN.91October 1, 2025
Casimersen (Amondys 45) (PDF)CP.PHAR.470April 1, 2025
Casirivimab and imdevimab (REGEN-COV) (PDF)CP.PHAR.520July 1, 2023
Celecoxib (Celebrex) (PDF)CP.PMN.122December 1, 2023
Cemiplimab-rwlc (Libtayo) (PDF)CP.PHAR.397March 1, 2026
Cemiplimab-rwlc (Libtayo) (PDF)CP.PHAR.397Version effective until March 1, 2026
Cenegermin-bkbj (Oxervate)(PDF)CP.PMN.186April 1, 2025
Cenobamate (Xcopri) (PDF)CP.PMN.231April 1, 2025
Ceritinib (Zykadia) (PDF)CP.PHAR.349September 1, 2025
Cerliponase alfa (Brineura) (PDF)CP.PHAR.338October 1, 2025
Cetuximab (Erbitux®) (PDF)CP.PHAR.317March 1, 2026
Cetuximab (Erbitux®) (PDF)CP.PHAR.317Version effective until March 1, 2026
Chenodiol (Chenodal) (PDF)CP.PMN.239December 1, 2025
Chlorambucil (Leukeran) (PDF)CP.PHAR.554March 1, 2026
Chlorambucil (Leukeran) (PDF)CP.PHAR.554Version effective until March 1, 2026
Chloramphenicol Sodium Succinate (PDF)CP.PHAR.388October 1, 2025
Cholic Acid (Cholbam) (PDF)CP.PHAR.390December 1, 2025
Ciclopirox (Penlac) (PDF)CP.PMN.24April 1, 2025
Ciltacabtagene Autoleucel (Carvykti) (PDF)CP.PHAR.533January 1, 2026
Cinacalcet (Sensipar) (PDF)CP.PHAR.61December 1, 2025
Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF)CP.PHAR.567April 1, 2025
Ciprofloxacin-Dexamethasone (Ciprodex) (PDF)CP.PMN.248Retire by March 1, 2026
Ciprofloxacin/Fluocinolone (Otovel) (PDF)CP.PMN.249March 1, 2026
Ciprofloxacin/Fluocinolone (Otovel) (PDF)CP.PMN.249Version effective until March 1, 2026
Cladribine (Mavenclad) (PDF)CP.PHAR.422October 1, 2025
Clascoterone (Winlevi) (PDF)CP.PMN.257April 1, 2025
 Clesrovimab-cfor (Enflonsia) (PDF)CP.PHAR.740October 1, 2025
Clobazam (Onfi) (PDF)CP.PMN.54December 1, 2025
CNS Stimulants (PDF)CP.PMN.92June 1, 2025
Cobimetinib (Cotellic) (PDF)CP.PHAR.380July 1, 2025
Colchicine (Colcrys, Lodoco) (PDF)CP.PMN.123April 1, 2025
Colesevelam (Welchol) (PDF)CP.PMN.250December 1, 2025
Collagenase (Xiaflex) (PDF)CP.PHAR.82October 1, 2025
Colonoscopy Preparation Products (PDF)CP.PCH.43December 1, 2025
Compounded Medications (PDF)CP.PMN.280October 1, 2025
Concizumab (NN7415) (PDF)CP.PHAR.625January 1, 2026
Concizumab (NN7415) (PDF)CP.PHAR.625Version effective until January 1, 2026
Conjugated Estrogens/Bazedoxifene (Duavee) (PDF)CP.PMN.258December 1, 2025
Continuous Glucose Monitors (PDF)CP.PMN.214March 1, 2026
Continuous Glucose Monitors (PDF)CP.PMN.214Version effective until March 1, 2026
Copanlisib (Aliqopa®) (PDF)CP.PHAR.357March 1, 2026
Copanlisib (Aliqopa®) (PDF)CP.PHAR.357Version effective until March 1, 2026
Corticosteroid Intravitreal Implants (Iluvien, Ozurdex, Retisert, Yutiq) (PDF)CP.PHAR.385October 1, 2025
Corticotropin (H.P. Acthar, Purified Cortrophin Gel) (PDF)HIM.PA.168October 1, 2025
Cosibelimab-Ipdl (Unloxcyt) (PDF)CP.PHAR.711August 1, 2025
Cosyntropin (Cortrosyn) (PDF)CP.PHAR.203June 1, 2025
Crinecerfont (Crenessity) (PDF)CP.PHAR.692December 1, 2025
Crisaborole (Eucrisa) (PDF)CP.PMN.110December 1, 2025
Crizanlizumab-tmca (Adakveo) (PDF)CP.PHAR.449October 1, 2025
Crizotinib (Xalkori) (PDF)CP.PHAR.90July 1, 2025
Crovalimab (PDF)CP.PHAR.664October 1, 2025
Cyclosporine (Cequa, Restasis, Verkazia, Vevye, Klarity-C) (PDF)CP.PMN.48October 1, 2025
Cysteamine Ophthalmic (Cystaran, Cystadrops) (PDF)CP.PMN.130July 1, 2025
Cysteamine oral (Cystagon, Procysbi) (PDF)CP.PHAR.155October 1, 2025
Cytomegalovirus Immune Globulin (Cytogam) (PDF)CP.PHAR.277October 1, 2025
Dabrafenib (Tafinlar) (PDF)CP.PHAR.239July 1, 2025
Dacomitinib (Vizimpro) (PDF)CP.PHAR.399March 1, 2026
Dacomitinib (Vizimpro) (PDF)CP.PHAR.399Version effective until March 1, 2026
Dalfampridine (Ampyra) (PDF)CP.PHAR.248July 1, 2025
Dalteparin (Fragmin) (PDF)CP.PHAR.225April 1, 2025
Danicopan (ALXN2040) (PDF)CP.PHAR.665December1, 2025
Daprodustat (Jesduvroq) (PDF)CP.PHAR.628July 1, 2025
Daptomycin (Cubicin, Cubicin RF) (PDF)CP.PHAR.351October 1, 2025
Dapsone (Aczone Gel) (PDF)CP.PCH.32December 1, 2025
Daratumumab (Darzalex) (PDF)CP.PHAR.310January 1, 2026
Darbepoetin alfa (Aranesp) (PDF)CP.PHAR.236September 1, 2025
Darolutamide (Nubeqa) (PDF)CP.PHAR.435December 1, 2025
Dasabuvir-Ombitasvir-Paritaprevir-Ritonavir (Viekira Pak) (PDF)HIM.PA.SP61October 1, 2025
Dasatinib (Sprycel, Phyrago) (PDF)CP.PHAR.72October 1, 2025
Dasiclucagon (ZP4207) (PDF)CP.PHAR.642December 1, 2023
Datopotamab Deruxtecan-dlnk (Datroway) (PDF)CP.PHAR.715November 1, 2025
DaxibotulinumtoxinA-lanm (Daxxify) (PDF)CP.PHAR.651December 1, 2025
Daunorubicin/cytarabine (Vyxeos®) (PDF)CP.PHAR.352March 1, 2026
Daunorubicin/cytarabine (Vyxeos®) (PDF)CP.PHAR.352Version effective until March 1, 2026
Decitabine-Cedazuridine (Inqovi) (PDF)CP.PHAR.479October 1, 2025
Deferasirox (Exjade Jadenu) (PDF)CP.PHAR.145December 1, 2025
Deferiprone (Ferriprox) (PDF)CP.PHAR.147December 1, 2025
Deferoxamine (Desferal) (PDF)CP.PHAR.146December 1, 2025
Deflazacort (Emflaza) (PDF)CP.PHAR.331April 1, 2025
Degarelix Acetate (Firmagon) (PDF)CP.PHAR.170December 1, 2025
Delafloxacin (Baxdela) (PDF)CP.PMN.115October 1, 2025
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF)CP.PCH.56January 1, 2026
Delgocitinib (Anzupgo) (PDF)CP.PHAR.744March 1, 2026
Denileukin Diftitox-cxdl (Lymphir) (PDF)CP.PHAR.693December 1, 2025
Denosumab (Prolia, Xgeva and biosimilars) (PDF)CP.PHAR.58March 1, 2026
Denosumab (Prolia, Xgeva and biosimilars) (PDF)CP.PHAR.58Version effective until March 1, 2026
Desmopressin Acetate (DDAVP, Stimate, Noctiva) (PDF)CP.PHAR.214June 1, 2025
Deutetrabenazine (Austedo, Austedo XR) (PDF)CP.PCH.42July 1, 2025
Dexrazoxane (Zinecard, Totect) (PDF)CP.PHAR.418September 1, 2025
Dextromethorphan-bupropion (Auvelity) (PDF)CP.PMN.284December 1, 2025
Dextromethorphan-Quinidine (Nuedexta) (PDF)CP.PMN.93April 1, 2025
Diazepam Nasal Spray (Libervant, Valtoco)(PDF)CP.PMN.216December 1, 2025
Diazoxide Choline (Vykat XR) (PDF)CP.PHAR.701December 1, 2025
Dichlorphenamide (Keveyis) (PDF)CP.PMN.261April 1, 2025
Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF)CP.PCH.28March 1, 2026
Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF)CP.PCH.28Version effective until March 1, 2026
DimethylFumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (PDF)CP.PHAR.249October 1, 2025
Enfuvirtide (Fuzeon) (PDF)CP.PHAR.41October 1, 2025
Dipeptidyl Peptidase-4 Inhibitors (PDF)HIM.PA.58May 1, 2025
Dolasetron (Anzemet) (PDF)CP.PMN.141October 1, 2025
Donanemab-azbt (Kinsunla) (PDF)CP.PHAR.594March 1, 2026
Donanemab-azbt (Kinsunla) (PDF)CP.PHAR.594Version effective until March 1, 2026
Donidalorsen (Dawnzera) (PDF)CP.PHAR.717January 1, 2026
Donidalorsen (Dawnzera) (PDF)CP.PHAR.717Version effective until January 1, 2026
Donislecel (Lantidra) (PDF)CP.PHAR.569December 1, 2023
Dornase alfa (Pulmozyme) (PDF)CP.PHAR.212October 1, 2025
Dordaviprone (Modeyso) (PDF)CP.PHAR.745March 1, 2026
Dostarlimab-gxly (Jemperli) (PDF)CP.PHAR.540October 1, 2025
Doxepin Hydrochloride Cream  (Prudoxin, Zonalon) (PDF)HIM.PA.147March 1, 2026
Doxepin Hydrochloride Cream  (Prudoxin, Zonalon) (PDF)HIM.PA.147Version effective until March 1, 2026
Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) (PDF)CP.PMN.79October 1, 2025
Dupilumab (Dupixent) (PDF)HIM.PA.SP69December 1, 2025
Durvalumab (Imfinzi) (PDF)CP.PHAR.339January 1, 2026
Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF)CP.PMN.128July 1, 2025
Duvelisib (Copiktra) (PDF)CP.PHAR.400March 1, 2026
Duvelisib (Copiktra) (PDF)CP.PHAR.400Version effective until March 1, 2026
Ecallantide (Kalbitor) (PDF)CP.PHAR.177October 1, 2025
Eculizumab (Soliris) (PDF)CP.PHAR.97December 1, 2025
Edaravone (Radicava, Radivaca ORS) (PDF)CP.PHAR.343September 1, 2025
Efgartigimod alfa, efgartigimod-hyaluronidase (Vyvgart, Vyvgart Hytrulo) (PDF)CP.PHAR.555
July 1, 2025
Efinaconazole (Jublia) (PDF)CP.PMN.25April 1, 2025
Eflornithine (Iwilfin) (PDF)CP.PHAR.670April 1, 2025
Elacestrant (Orserdu) (PDF)CP.PHAR.623September 1, 2025
Eladocagene Exuparvovec-tneq (Kebilidi) (PDF)CP.PHAR.595January 1, 2026
Elagolix (Orilissa), elagolix-estradiol-norethindrone (Oriahnn) (PDF)CP.PHAR.136December 1, 2025
Elapegademase-lvlr (Revcovi) (PDF)CP.PHAR.419July 1, 2025
Elbasvir/Grazoprevir (Zepatier) (PDF)HIM.PA.SP62December 1, 2025
Elafibranor (Iqirvo) (PDF)CP.PHAR.688October 1, 2025
Elamipretide (Forzinity) (PDF)CP.PHAR.680January 1, 2026
Eliglustat (Cerdelga) (PDF)CP.PHAR.153July 1, 2025
Elexacaftor-ivacaftor-tezacaftor (Trikafta) (PDF)CP.PHAR.440October 1, 2025
Elosulfase Alfa (Vimizim) (PDF)CP.PHAR.162July 1, 2025
Elotuzumab (Empliciti) (PDF)CP.PHAR.308December 1, 2025
Elranatamab-bcmm (Elrexfio) (PDF)CP.PHAR.652March 1, 2026
Elranatamab-bcmm (Elrexfio) (PDF)CP.PHAR.652Version effective until March 1, 2026
Eltrombopag (Promacta®) (PDF)CP.PHAR.180January 1, 2026
Eltrombopag (Promacta®) (PDF)CP.PHAR.180Version effective until January 1, 2026
Eluxadoline (Viberzi) (PDF)CP.PMN.170December 1, 2025
Elivaldogene Autotemcel (PDF)CP.PHAR.556March 1, 2026
Elivaldogene Autotemcel (PDF)CP.PHAR.556Version effective until March 1, 2026
Emapalumab-lzsg (Gamifant)(PDF)CP.PHAR.402October 1, 2025
Emicizumab-kxwh (Hemlibra) (PDF)CP.PHAR.370April 1, 2025
Emtricitabine/Tenofovir Alafenamide (Descovy) (PDF)CP.PMN.235July 1, 2025
Enasidenib (Idhifa) (PDF)CP.PHAR.363December 1, 2025
Encorafenib (Braftovi) (PDF)CP.PHAR.127July 1, 2025
Enfuvirtide (Fuzeon) (PDF)CP.PHAR.41July 1, 2021
Enfortumab Vedotin-ejfv (Padcev) (PDF)CP.PHAR.455April 1, 2025
Enoxaparin (Lovenox) (PDF)CP.PHAR.224April 1, 2025
Ensartinib (Ensacove) (PDF)CP.PHAR.712April 1, 2025
Entecavir (Baraclude) (PDF)HIM.PA.08November 1, 2025
Entrectinib (Rozlytrek) (PDF)CP.PHAR.441March 1, 2026
Entrectinib (Rozlytrek) (PDF)CP.PHAR.441Version effective until March 1, 2026
Enzalutamide (Xtandi) (PDF)CP.PHAR.106April 1, 2025
Enzalutamide (Xtandi) (PDF)HIM.PA.164May 1, 2023
Epinephrine (Epipen, Epipen Jr, Neffy, Auvi-Q) (PDF)CP.PCH.55December 1, 2025
Epcoritamab-bysp (Epkinly) (PDF)CP.PHAR.634October 1, 2025
Eplontersen (Wainua) (PDF)CP.PHAR.633July 1, 2025
Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF)CP.PHAR.237August 1, 2025
Epoprostenol (PDF)CP.PHAR.192April 1, 2025
Eptinezumab-jjmr (Vyepti) (PDF)HIM.PA.SP64December 1, 2025
Erdafitinib (Balversa) (PDF)CP.PHAR.423October 1, 2025
Erenumab-aaoe (Aimovig) (PDF)HIM.PA.SP65December 1, 2025
Eribulin Mesylate (Halaven®) (PDF)CP.PHAR.318March 1, 2026
Eribulin Mesylate (Halaven®) (PDF)CP.PHAR.318Version effective until March 1, 2026
Erlotinib (Tarceva) (PDF)CP.PHAR.74July 1, 2025
Erwinia Asparaginase (Erwinaze) (PDF)CP.PHAR.301April 1, 2025
Esketamine (Spravato) (PDF)CP.PMN.199July 1, 2025
Estradiol Vaginal Ring (Femring) (PDF)CP.PMN.263October 1, 2025
Etelcalcetide (Parsabiv) (PDF)CP.PHAR.379October 1, 2025
Eteplirsen (Exondys 51) (PDF)CP.PHAR.288April 1, 2025
Etranacogene Dezaparvovec (Hemgenix) (PDF)CP.PHAR.580January 1, 2026
Everolimus (Afinitor, Afinitor Disperz, Zortress)(PDF)CP.PHAR.63April 1, 2025
Evinacumab-dgnb (Evkeeza) (PDF)CP.PHAR.511March 1, 2022
Evinacumab-dgnb (Evkeeza) (PDF)HIM.PA.166February 1, 2026
Evinacumab-dgnb (Evkeeza) (PDF)HIM.PA.166Version effective until February 1, 2026
Evolocumab (Repatha) (PDF)HIM.PA.156December 1, 2025
Exagamglogene autotemcel (Casgevy) (PDF)CP.PHAR.603January 1, 2026
Factor IX (Human, Recombinant) (PDF)CP.PHAR.218April 1, 2025
Factor IX Complex Human (Bebulin®, Profilnine®) (PDF)CP.PHAR.219April 1, 2025
Factor VIIa, Recombinant (NovoSeven® RT) (PDF)CP.PHAR.220June 1, 2025
Factor VIII  (PDF)CP.PHAR.215August 1, 2025
Factor VIII/von Willebrand Factor Complex (Human - Alphanate®, Humate-P®, Wilate®) (PDF)CP.PHAR.216February 1, 2026
Factor VIII/von Willebrand Factor Complex (Human - Alphanate®, Humate-P®, Wilate®) (PDF)CP.PHAR.216Version effective until February 1, 2026
Factor XIII A-Subunit, Recombinant (Tretten®)CP.PHAR.222April 1, 2025
Factor XIII, Human (Corifact®) (PDF)CP.PHAR.221April 1, 2025
Fam-trastuzumab Deruxtecan-nxki (Enhertu) (PDF)CP.PHAR.456April 1, 2025
Famotidine-Ibuprofen (Duexis) (PDF)CP.PMN.120October 1, 2025
Faricimab (Vabysmo) (PDF)CP.PHAR.581April 1, 2025
Febuxostat (Uloric) (PDF)CP.PMN.57April 1, 2025
Fecal microbiota, live-jslm (Rebyota) (PDF)CP.PHAR.613April 1, 2025
Fecal microbiota spores, live-brpk (Vowst) (PDF)CP.PHAR.632October 1, 2025
Fedratinib (Inrebic) (PDF)CP.PHAR.442March 1, 2026
Fedratinib (Inrebic) (PDF)CP.PHAR.442Version effective until March 1, 2026
Fenfluramine (Fintepla) (PDF)CP.PMN.246October 1, 2025
Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF)CP.PMN.127July 1, 2025
Ferric Carboxymaltose (Injectafer) (PDF)CP.PHAR.234January 1, 2026
Ferric Carboxymaltose (Injectafer) (PDF)CP.PHAR.234Version effective until January 1, 2026
Ferric Derisomaltose (Monoferric) (PDF)CP.PHAR.480January 1, 2026
Ferric Derisomaltose (Monoferric) (PDF)CP.PHAR.480Version effective until January 1, 2026
Ferric gluconate (Ferrlecit®) (PDF)CP.PHAR.166July 1, 2023
Ferric Maltol (Accrufer) (PDF)CP.PMN.213December 1, 2025
Ferric Pyrophosphate (Triferic, Triferic Avnu) (PDF)CP.PHAR.624July 1, 2025
Ferumoxytol (Feraheme®) (PDF)CP.PHAR.165January 1, 2026
Ferumoxytol (Feraheme®) (PDF)CP.PHAR.165Version effective until January 1, 2026
Fezolinetant (Veozah) (PDF)CP.PMN.289October 1, 2025
Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF)CP.PHAR.643January 1, 2026
Flibanserin (Addyi) (PDF)CP.PHAR.446January 1, 2025
Fibrinogen concentrate (human) (Fibryga, RiaSTAP) (PDF)CP.PHAR.526July 1, 2025
Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix) (PDF)CP.PHAR.297October 1, 2025
Finerenone (Kerendia) (PDF)CP.PMN.266March 1, 2026
Finerenone (Kerendia) (PDF)CP.PMN.266Version effective until March 1, 2026
Fingolimod (Gilenya, Tascenso ODT) (PDF)CP.PCH.38July 1, 2025
Fingolimod (Gilenya, Tascenso ODT) (PDF)CP.PHAR.251October  1, 2025
Fitusiran (Qfitlia) (PDF)CP.PHAR.706November 1, 2025
Fluorouracil Cream (Tolak) (PDF)CP.PMN.165December 1, 2025
Fluticasone Propionate (Xhance) (PDF)CP.PMN.95December 1, 2025
Fondaparinux (Arixtra) (PDF)CP.PHAR.226April 1, 2025
No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF)HIM.PA.33December 1, 2025
Fosdenopterin (Nulibry) (PDF)CP.PHAR.471November 1, 2025
Fostamatinib (Tavalisse) (PDF)CP.PHAR.24January 1, 2026
Fostamatinib (Tavalisse) (PDF)CP.PHAR.24Version effective until January 1, 2026
Fostemsavir (Rukobia) (PDF)CP.PHAR.516October 1, 2025
Fremanezumb-vfrm (PDF)HIM.PA.SP66December 1, 2025
Fruquintinib (Fruzaqla) (PDF)CP.PHAR.666April 1, 2025
Fulvestrant (Faslodex Injection) (PDF)CP.PHAR.424December 1, 2025
Furosemide (Furoscix) (PDF)CP.PHAR.608July 1, 2025
Futibatinib (Lytgobi) (PDF)CP.PHAR.604April 1, 2025
Gabapentin ER (Gralise, Horizant) (PDF)CP.PMN.240December 1, 2025
Galcanezumab-gnlm (Emgality) (PDF)HIM.PA.SP67December 1, 2025
Galsulfase (Naglazyme) (PDF)CP.PHAR.161July 1, 2025
Ganaxolone (Ztalmy) (PDF)CP.PMN.278July 1, 2025
Garadacimab (CSL312)_PEPP (PDF)CP.PHAR.673March 1. 2026
Garadacimab (CSL312)_PEPP (PDF)CP.PHAR.673Version effective until March 1, 2026
Gefitinib (Iressa) (PDF)CP.PHAR.68July 1, 2025
Gemcitabine Intravesical System (Inlexzo) CP.PHAR.753December 1, 2025
Gemtuzumab ozogamicin (Mylotarg®) (PDF)CP.PHAR.358December 1, 2025
Gilteritinib (Xospata) (PDF)CP.PHAR.412April 1, 2025
Givinostat (ITF2357) (PDF)CP.PHAR.644October 1, 2025
Givosiran (Givlaari) (PDF)CP.PHAR.457April 1, 2025
Glasdegib (Daurismo)(PDF)CP.PHAR.413April 1, 2025
Glatiramer (Copaxone, Glatopa) (PDF)CP.PHAR.252July 1, 2025
Glaucoma Agents (Omlonti, Rhopressa, Rocklatan, Vyzulta) (PDF)CP.PMN.286December 1, 2025
Glecaprevir-Pibrentasvir (PDF)HIM.PA.SP36December 1, 2025
Glofitamab-gxbm (Columvi) (PDF)CP.PHAR.636October 1, 2025
Glucagon-Like Peptide-1 Receptor Agonists (PDF)HIM.PA.53March 1, 2026
Glucagon-Like Peptide-1 Receptor Agonists (PDF)HIM.PA.53Version effective until March 1, 2026
Glycerol phenylbutyrate (Ravicti®) (PDF)CP.PHAR.207April 1, 2025
Golodirsen (Vyondys 53) (PDF)CP.PHAR.453April 1, 2025
Goserelin acetate (Zoladex®) (PDF)CP.PHAR.171March 1, 2026
Goserelin acetate (Zoladex®) (PDF)CP.PHAR.171Version effective until March 1, 2026
Granisetron (Kytril, Sancuso, Sustol) (PDF)CP.PMN.74October 1, 2025
Halcinonide (Halog) (PDF)HIM.PA.20December 1, 2025
Halobetasol Propionate Lotion (Bryhali, Lexette, Ultravate) (PDF)CP.PMN.180December 1, 2025
Halobetasol Propionate/Tazarotene (Duobrii) (PDF)CP.PMN.208October 1, 2025
Hemin (Panhematin®) (PDF)CP.PHAR.181April 1, 2025
Histrelin acetate (Vantas®, Supprelin LA®) (PDF)CP.PHAR.172July 1, 2025
House dust mite allergen extract (Odactra®) (PDF)CP.PMN.111October 1, 2025
Human Growth Hormone (Somapacitan, Somatropin) (PDF)HIM.PA.161February 1, 2026
Human Growth Hormone (Somapacitan, Somatropin) (PDF)HIM.PA.161Version effective until February 1, 2026
Hyaluronate Derivatives (PDF)CP.PHAR.05December 1, 2025
Hydroxyprogesterone Caproate (Makena/compound) (PDF)CP.PHAR.14July 1, 2025
Hydroxyurea (Siklos, Xromi) (PDF)CP.PMN.193November 1, 2025
ibalizumab-uiyk (Trogarzo) (PDF)CP.PHAR.378October 1, 2025
Ibandronate sodium (PDF)CP.PHAR.189October 1, 2025
Ibrutinib (Imbruvica) (PDF)CP.PHAR.126June 1, 2024
Icatibant (Firazyr®) (PDF)CP.PHAR.178October 1, 2025
Icosapent ethyl (Vascepa) (PDF)CP.PMN.187April 1, 2025
Idecabtagene vicleucel (Abecma) (PDF)CP.PHAR.481January 1, 2026
Idelalisib (Zydelig) (PDF)CP.PHAR.133December 1, 2025
Idursulfase (Elaprase) (PDF)CP.PHAR.156July 1, 2025
Iloperidone (Fanapt) (PDF)CP.PMN.32October 1, 2025
Iloprost (Ventavis®) (PDF)CP.PHAR.193April 1, 2025
Imatinib (Gleevec, Imkeldi) (PDF)CP.PHAR.65July 1, 2025
Imetelstat (Rytelo) (PDF)CP.PHAR.690October 1, 2025
Imiglucerase (Cerezyme) (PDF)CP.PHAR.154July 1, 2025
Imlunestrant (Inluriyo) CP.PHAR.754December 1, 2025
Immune Globulins (PDF)HIM.PA.178January 1, 2026
Immune Globulins (PDF)CP.PHAR.103Retire by February 1, 2026
Immune Globulins for PANS/PANDAS (PDF)AR.CP.PHAR.103February 1, 2026
Inavolisib (Itovebi) (PDF)CP.PHAR.702March 1, 2026
Inavolisib (Itovebi) (PDF)CP.PHAR.702Version effective until March 1, 2026
IncobotulinumtoxinA (Xeomin) (PDF)CP.PHAR.231October 1, 2025
Inhaled Agents for Asthma and COPD (PDF)HIM.PA.153January 1, 2026
Inhaled Agents for Asthma and COPD (PDF)HIM.PA.153Version effective until January 1, 2026
Infertility and Fertility Preservation (PDF)CP.PHAR.131March 1, 2026
Infertility and Fertility Preservation (PDF)CP.PHAR.131Version effective until March 1, 2026
Inclisiran (Leqvio) (PDF)CP.PHAR.568October 1, 2025
Inebilizumab (PDF)CP.PHAR.458December 1, 2025
Inotersen (Tegsedi) (PDF)CP.PHAR.405July 1, 2025
Inotuzumab ozogamicin (Besponsa®) (PDF)CP.PHAR.359March 1, 2026
Inotuzumab ozogamicin (Besponsa®) (PDF)CP.PHAR.359Version effective until March 1, 2026
Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF)CP.PHAR.534November 1, 2025
Insulin detemir (Levemir) (PDF)HIM.PA.171January 1, 2026
Insulin glargine (Rezvoglar, Semglee, Toujeo) (PDF)HIM.PA.09January 1, 2026
Interferon Beta-1a (Avonex, Rebif) (PDF)CP.PHAR.255July 1, 2025
Interferon beta-1b (Betaseron, Extavia) (PDF)CP.PCH.46October 1, 2025
Interferon Gamma- 1b (Actimmune) (PDF)CP.PHAR.52April 1, 2025
Intrathecal Baclofen (Gablofen, Lioresal) (PDF)CP.PHAR.149December 1, 2023
Iobenguane I-131 (Azedra) (PDF)CP.PHAR.459April 1, 2025
Ipilimumab (Yervoy) (PDF)CP.PHAR.319October 1, 2025
Iptacopan (LNP023) (PDF)CP.PHAR.656December 1, 2025
Irinotecan Liposome (Onivyde) (PDF)CP.PHAR.304March 1, 2026
Irinotecan Liposome (Onivyde) (PDF)CP.PHAR.304Version effective until March 1, 2026
Iron sucrose (Venofer®) (PDF)CP.PHAR.167July 1, 2023
Isatuximab-irfc (Sarclisa) (PDF)CP.PHAR.482July 1, 2025
isavuconazonium (Cresemba®) (PDF)CP.PMN.154March 1, 2026
isavuconazonium (Cresemba®) (PDF)CP.PMN.154Version effective until March 1, 2026
Isotretinoin (Claravis, Absorica, Absorica LD, Myorisan, Zenatane, Amnesteem) (PDF)CP.PMN.143December 1, 2025
Istradefylline (Nourianz) (PDF)CP.PMN.217April 1, 2025
Itraconazole (Sporanox, Tolsura) (PDF)CP.PMN.124July 1, 2025
Ivabradine (Corlanor) (PDF)CP.PMN.70June 1, 2025
Ivacaftor (Kalydeco) (PDF)CP.PHAR.210December 1, 2025
Ivermectin (Stromectol, Sklice)CP.PMN.269October 1, 2025
Ivosidenib (Tibsovo) (PDF)CP.PHAR.137March 1, 2026
Ivosidenib (Tibsovo) (PDF)CP.PHAR.137Version effective until March 1, 2026
Ixazomib (Ninlaro) (PDF)CP.PHAR.302December 1, 2025
Ketamine (Ketalar) (PDF)CP.PMN.296October 1, 2025
Ketorolac nasal spray (Sprix) (PDF)CP.PMN.282December 1, 2025
Lacosamide (Vimpat) (PDF)CP.PMN.155August 1, 2022
L-glutamine (Endari) (PDF)CP.PMN.116December 1, 2025
Lactic Acid/Citric Acid/Potassium Bitartrate (Phexxi) (PDF)CP.PMN.251December 1, 2022
Lanadelumab-fylo (Takhzyro) (PDF)HIM.PA.172October 1, 2025
Lanreotide (Somatuline Depot and Unbranded) (PDF)CP.PHAR.391December 1, 2025
lapatinib (Tykerb®) (PDF)CP.PHAR.79March 1, 2026
lapatinib (Tykerb®) (PDF)CP.PHAR.79Version effective until March 1, 2026
Laronidase (Aldurazyme) (PDF)CP.PHAR.152July 1, 2025
Larotrectinib (Vitrakvi)(PDF)CP.PHAR.414October 1, 2025
Lasmiditan (Reyvow) (PDF)CP.PMN.218December 1, 2025
Latanoprostene Bunod (Vyzulta) (PDF)CP.PMN.108May 1, 2023
Lazertinib (Lazcluze) (PDF)CP.PHAR.695December 1, 2025
Lebrikizumab (Ebglyss) (PDF)CP.PCH.58March 1, 2026
Lebrikizumab (Ebglyss) (PDF)CP.PHAR.704Retire by March 1, 2026
Lecanemab-irmb (Leqembi) (PDF)CP.PHAR.596March 1, 2026
Lecanemab-irmb (Leqembi) (PDF)CP.PHAR.596Version effective until March 1, 2026
Ledipasvir-Sofosbuvir (Harvoni) (PDF)HIM.PA.SP3December 1, 2025
Lefamulin (Xenleta) (PDF)CP.PMN.219October 1, 2025
Lenacapavir (Sunlenca) (PDF)CP.PHAR.622December 1, 2025
Lenalidomide (Revlimid) (PDF)CP.PHAR.71September 1, 2025
Lenvatinib (Lenvima) (PDF)CP.PHAR.138March 1, 2026
Lenvatinib (Lenvima) (PDF)CP.PHAR.138Version effective until March 1, 2026
Leniolisib (Joenja) (PDF)CP.PHAR.597December 1, 2025
Letermovir (Prevymis) (PDF)CP.PHAR.367February 1, 2026
Letermovir (Prevymis) (PDF)CP.PHAR.367Version effective until February 1, 2026
Leucovorin Injection (PDF)CP.PHAR.393March 1, 2026
Leucovorin Injection (PDF)CP.PHAR.393Version effective until March 1, 2026
 Levacetylleucine (Aqneursa) (PDF)CP.PHAR.682March 1, 2026
 Levacetylleucine (Aqneursa) (PDF)CP.PHAR.682Version effective until March 1, 2026
Levodopa Inhalation Powder (Inbrija) (PDF)CP.PMN.267March 1, 2026
Levodopa Inhalation Powder (Inbrija) (PDF)CP.PMN.267Version effective until March 1, 2026
Levoleucovorin (Fusilev, Khapzory) (PDF)CP.PHAR.151December 1, 2025
Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF)CP.PHAR.173January 1, 2025
Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF)CP.PCH.53March 1, 2026
Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF)CP.PCH.53Version effective until March 1, 2026
Levoketoconazole (Recorlev) (PDF)CP.PMN.275July 1, 2025
Levomilnacipran (Fetzima) (PDF)HIM.PA.125October 1, 2025
Lidocaine Transdermal (Lidoderm, ZTlido) (PDF)CP.PMN.08December 1, 2025
Lifileucel (Amtagvi) (PDF)CP.PHAR.598January 1, 2026
Lifitegrast (Xiidra®) (PDF)CP.PMN.73April 1, 2025
Linaclotide (Linzess) (PDF)CP.PMN.71December 1, 2023
Linezolid (Zyvox) (PDF)CP.PMN.27October 1, 2025
 Linvoseltamab-gcpt (Lynozyfic) (PDF)CP.PHAR.743November 1, 2025
Lisocabtagene Maraleucel (Breyanzi) (PDF)CP.PHAR.483February 1, 2026
Lisocabtagene Maraleucel (Breyanzi) (PDF)CP.PHAR.483Version effective until February 1, 2026
Lofexidine (Lucemyra) (PDF)CP.PMN.152October 1, 2025
Lomustine (Gleostine) (PDF)CP.PHAR.507December 1, 2025
Lonafarnib (Zokinvy) (PDF)CP.PHAR.499April 1, 2025
Loncastuximab tesirine-lpyl (Zynlonta) (PDF)CP.PHAR.539October 1, 2025
Lorlatinib (Lorbrena)(PDF)CP.PHAR.406September 1, 2025
Loteprednol etabonate (Eysuvis) (PDF)CP.PMN.260April 1, 2025
Lotilaner (Xdemvy) (PDF)CP.PMN.291March 1, 2026
Lotilaner (Xdemvy) (PDF)CP.PMN.291Version effective until March 1, 2026
Lovotibeglogene Autotemcel (Lovo-Cel) (PDF)CP.PHAR.627January 1, 2026
Lubiprostone (Amitiza) (PDF)CP.PMN.142March 1, 2026
Lubiprostone (Amitiza) (PDF)CP.PMN.142Version effective until March 1, 2026
Luliconazole Cream (Luzu) (PDF)CP.PMN.166April 1, 2025
Lumacaftor-Ivacaftor (Orkambi) (PDF)CP.PHAR.213December 1, 2025
Lumasiran (Oxlumo) (PDF)CP.PHAR.473April 1, 2025
Lumateperone (Caplyta) (PDF)CP.PMN.232January 1, 2026
Lurbinectedin (Zepzelca) (PDF)CP.PHAR.500January 1, 2026
Lurasidone (Latuda) (PDF)CP.PMN.50March 1, 2023
Luspatercept-aamt (Reblozyl) (PDF)CP.PHAR.450April 1, 2025
Lusutrombopag (Mulpleta)(PDF)CP.PHAR.407April 1, 2025
Lutetium Lu 177 Dotatate (Lutathera) (PDF)CP.PHAR.384October 1, 2025
Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) 09.09.22.docxCP.PHAR.582July 1, 2025
Macitentan (Opsumit) (PDF)CP.PHAR.194April 1, 2025
Macitentan (Opsumit®) (PDF)CP.PCH.31March 1, 2022
Mannitol (Bronchitol) (PDF)CP.PHAR.518October 1, 2025
Maralixibat (Livmarli) (PDF)CP.PHAR.543December 1, 2025
Margetuximab-cmkb (Margenza) (PDF)CP.PHAR.522April 1, 2025
Maribavir (Livtencity) (PDF)CP.PMN.271April 1, 2025
Marstacimab-hncq (Hympavzi) (PDF)CP.PHAR.674August 1, 2025
Mavacamten (MYK-461) (PDF)CP.PMN.272October 1, 2025
Mavorixafor (Xolremdi)CP.PHAR.679July 1, 2025
Mecamylamine (Vecamyl) (PDF)CP.PMN.136July 1, 2025
Mecasermin (Increlex) (PDF)CP.PHAR.150October 1, 2025
 Mechlorethamine (Valchlor) (PDF)CP.PHAR.381October 1, 2025
Megestrol Acetate 125 mg/mL Oral Suspension (Megace ES) (PDF)CP.PMN.179December 1, 2025
Melphalan (Hepzato) (PDF)CP.PHAR.653December 1, 2025
Melphalan flufenamide (Pepaxto) (PDF)CP.PHAR.535July 1, 2025
Memantine (Namenda XR, Namzaric) (PDF)CP.PCH.30October 1, 2025
Mepolizumab (Nucala) (PDF)HIM.PA.175January 1, 2026
Mepolizumab (Nucala) (PDF)HIM.PA.175Version effective until January 1, 2026
Mercaptopurine (Purixan) (PDF)CP.PHAR.447December 1, 2025
Metformin ER (Glumetza, Fortamet) (PDF)CP.PMN.72April 1, 2025
Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex) (PDF)CP.PHAR.134March 1, 2026
Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex) (PDF)CP.PHAR.134Version effective until March 1, 2026
Methoxsalen (Uvadex) (PDF)HIM.PA.17March 1, 2026
Methoxsalen (Uvadex) (PDF)HIM.PA.17Version effective until March 1, 2026
Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF)CP.PHAR.238September 1, 2025
Methylnaltrexone Bromide (Relistor) (PDF)CP.PMN.169December 1, 2025
Metoclopramide (Gimoti) (PDF)CP.PMN.252December 1, 2025
Metreleptin (Myalept) (PDF)CP.PHAR.425October 1, 2025
Midazolam (Nayzilam) (PDF)CP.PMN.211October 1, 2025
Midostaurin (Rydapt) (PDF)CP.PHAR.344July 1, 2025
Mifepristone (Korlym) (PDF)CP.PHAR.101June 1, 2025
Migalastat (Galafold) (PDF)CP.PHAR.394July 1, 2025
Miglustat (Zavesca) (PDF)CP.PHAR.164September 1, 2025
Milnacipran (Savella) (PDF)CP.PMN.125October 1, 2025
Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF)CP.PMN.80October 1, 2025
Minocycline micronized foam (Amzeeq) (PDF)CP.PMN.242December 1, 2022
Mirdametinib (Gomekli) (PDF)CP.PHAR.718July 1, 2025
Mirvetuximab soravtansine-gynx (Elahere) (PDF)CP.PHAR.617April 1, 2025
Mitapivat (Pyrukynd) (PDF)CP.PHAR.558December 1, 2025
Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF)CP.PHAR.495December 1, 2025
Mitoxantrone  (PDF)CP.PHAR.258July 1, 2025
Mixed pollens allergen extract (Oralair) (PDF)CP.PMN.85October 1, 2025
Mobocertinib (Exkivity) (PDF)CP.PHAR.559December 1, 2025
Modafinil (Provigil) (PDF)CP.PMN.39July 1, 2025
Mogamulizumab-kpkc (Poteligeo) (PDF)CP.PHAR.139December 1, 2025
Momelotinib (Ojjaara) (PDF)CP.PHAR.654January 1, 2025
 Mometasone furoate (Sinuva) (PDF)CP.PHAR.448October 1, 2025
Mometasone (Nasonex) (PDF)HIM.PA.93Retire by March 1, 2026
Montelukast oral granules (Singulair) (PDF)HIM.PA.129December 1, 2023
Mosunetuzumab-axgb (Lunsumio) (PDF)CP.PHAR.618April 1, 2025
Motixafortide (Aphexda) (PDF)CP.PHAR.655March 1, 2026
Motixafortide (Aphexda) (PDF)CP.PHAR.655Version effective until March 1, 2026
Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF)CP.PHAR.398Version effective until March 1, 2026
Nabumatone Double-Strength (Relafen DS) (PDF)CP.PMN.287October 1, 2025
Nadofaragene Firadenovec (Instiladrin)(PDF)CP.PHAR.461December 1, 2025
Nafarelin acetate (Synarel®) (PDF)CP.PHAR.174July 1, 2025
Naldemedine (Symproic) (PDF)CP.PMN.112December 1, 2025
Nalmefene (Opvee) (PDF)CP.PHAR.638October 1, 2025
Naloxegol (Movantik) (PDF)HIM.PA.167December 1, 2025
Naproxen/Esomeprazole (Vimovo) (PDF)CP.PMN.117October 1, 2025
Naproxen oral suspension (Naprosyn) (PDF)HIM.PA.130December 1, 2025
Narsoplimab (OMS721) (PDF)CP.PHAR.527June 1, 2024
Natalizumab (Tysabri) (PDF)CP.PHAR.259March 1, 2026
Natalizumab (Tysabri) (PDF)CP.PHAR.259Version effective until March 1, 2026
Naxitamab-gqgk (Danyelza) CP.PHAR.523April 1, 2025
Necitumumab (Portrazza®) (PDF)CP.PHAR.320December  1, 2025
Nedosiran (DCR-PHXC) (PDF)CP.PHAR.619September 1, 2025
Nemolizumab-ito (Nemluvio) (PDF)CP.PCH.59March 1, 2026
Nemolizumab-ito (Nemluvio) (PDF)CP.PHAR.703Retire by March 1, 2026
Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF)CP.PMN.167December 1, 2025
 Nerandomilast(Jascayd) (PDF)CP.PHAR.759January 1, 2026
Neratinib (Nerlynx) (PDF)CP.PHAR.365March 1, 2026
Neratinib (Nerlynx) (PDF)CP.PHAR.365Version effective until March 1, 2026
Netarsudil (Rhopressa), Netarsudil-Latanoprost (Rocklatan) (PDF)CP.PMN.118May 1, 2023
Netupitant and Palonosetron (Akynzeo) (PDF)CP.PMN.158October 1, 2025
Nifurtimox (Lampit) ^ (PDF)CP.PMN.256December 1, 2025
Nilotinib (Tasigna, Danziten) (PDF)CP.PHAR.76July 1, 2025
Nintedanib (Ofev) (PDF)CP.PCH.54October 1, 2025
Nipocalimab-aahu (Imaavy) (PDF)CP.PHAR.720November 1, 2025
Nitisinone (Nityr, Orfadin) (PDF)CP.PHAR.132December 1, 2025
Niraparib (Zejula) (PDF)CP.PHAR.408December 1, 2025
Niraparib and Abiraterone (Akeega) (PDF)CP.PHAR.645December 1, 2025
Nirmatrelvir-Ritonavir (Paxlovid) (PDF)CP.PMN.288October 1, 2025
Nirogacestat (Ogsiveo) (PDF)CP.PHAR.671April 1, 2025
Nirsevimab (Beyfortus) (PDF)CP.PHAR.614October 1, 2025
Nitazoxanide (Alinia) (PDF)HIM.PA.152December 1, 2025
Nivolumab, Nivolumab Hyaluronidase-nvhy (Opdivo, Opdivo Qvantig) (PDF)CP.PHAR.121December 1, 2025
Nivolumab and Relatlimab (Opdualag) (PDF)CP.PHAR.588October 1, 2025
Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF)CP.PHAR.684October 1, 2025
Non-Calcium Phosphate Binders (Auryxia, Fosrenol, Renagel, Renvela, Velphoro) (PDF)CP.PMN.04December 1, 2025
Non-Formulary and Formulary Contraceptives (PDF)HIM.PA.100July 1, 2025
Non-Formulary Test Strips (PDF)HIM.PA.34April 1, 2025
Nusinersen (Spinraza®) (PDF)CP.PHAR.327October 1, 2025
Obecabtagene autoleucel (Aucatzyl) (PDF)CP.PHAR.675January 1, 2026
Obeticholic acid (Ocaliva) (PDF)CP.PHAR.287December 1, 2025
Obinutuzumab (Gazyva®) (PDF)CP.PHAR.305March 1, 2026
Obinutuzumab (Gazyva®) (PDF)CP.PHAR.305Version effective until March 1, 2026
Ocrelizumab (Ocrevus) (PDF)CP.PHAR.335October 1, 2025
Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF)CP.PHAR.40June 1, 2025
Odevixibat (Bylvay) (PDF)CP.PHAR.528November 1, 2025
Ofatumumab (Arzerra, Kesimpta) (PDF)CP.PHAR.306October 1, 2025
Off-label Policy (PDF)HIM.PA.154December 1, 2025
Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF)CP.PHAR.292October 1, 2025
Olanzapine-samidorphan (Lybalvi) (PDF)CP.PMN.265October 1, 2025
Olaparib (Lynparza) (PDF)CP.PHAR.360April 1, 2025
Olaratumab (Lartruvo®) (PDF)CP.PHAR.326December 1, 2023
Olezarsen (Tryngolza) (PDF)CP.PHAR.689October 1, 2025
Olipudase alfa-rpcp (Xenpozyme) 09.08.22.docxCP.PHAR.586October 1, 2025
Olutasidenib (Rezlidhia) (PDF)CP.PHAR.615April 1, 2025
Omacetaxine (Synribo) (PDF)CP.PHAR.108September 1, 2025
Omadacycline (Nuzyra)(PDF)CP.PMN.188October 1, 2025
Omalizumab (Xolair) (PDF)CP.PCH.49November 1, 2025
Omalizumab (Xolair®) (PDF)CP.PHAR.01August 1, 2024
Omaveloxolone (Skyclarys) (PDF)CP.PHAR.590July 1, 2025
Omburtamab (Omblastys) (PDF)CP.PHAR.585December 1, 2023
OnabotulinumtoxinA (Botox) (PDF)CP.PHAR.232October 1, 2025
Onasemnogene abeparvovec (Zolgensma) (PDF)CP.PHAR.421January 1, 2026
Ondansetron (Zuplenz) (PDF)CP.PMN.45August 1, 2024
Ophthalmic Corticosteroids (PDF)HIM.PA.03March 1, 2026
Ophthalmic Corticosteroids (PDF)HIM.PA.03Version effective until March 1, 2026
Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF)CP.PHAR.536July 1, 2025
Opicapone (Ongentys) (PDF)CP.PMN.245October  1, 2025
Opioid Analgesics (PDF)HIM.PA.139February 1, 2026
Opioid Analgesics (PDF)HIM.PA.139Version effective until February 1, 2026
Osilodrostat (Isturisa) (PDF)CP.PHAR.487October 1, 2025
Osimertinib (Tagrisso) (PDF)CP.PHAR.294July 1, 2025
Ospemifene (Osphena) (PDF)CP.PMN.168December 1, 2025
Overactive Bladder Agents (PDF)CP.PMN.198September 1, 2025
Oxymetazoline (Rhofade, Upneeq) (PDF)CP.PMN.86October 1, 2025
Ozanimod (Zeposia) (PDF)CP.PHAR.462March 1, 2026
Ozanimod (Zeposia) (PDF)CP.PHAR.462Version effective until March 1, 2026
Ozenoxacin (Xepi) (PDF)CP.PMN.119October 1, 2025
Paclitaxel, Protein-Bound (Abraxane) (PDF)CP.PHAR.176October 1, 2025
Pacritinib (Vonjo) (PDF)CP.PHAR.583July 1, 2025
Palbociclib (Ibrance) (PDF)HIM.PA.173March 1, 2026
Palbociclib (Ibrance) (PDF)HIM.PA.173Version effective until March 1, 2026
Paliperidone inj (Invega Sustenna, Invega Trinza, Invega Hafyera) (PDF)CP.PHAR.291October 1, 2025
Palivizumab (Synagis) (PDF)CP.PHAR.16October 1, 2025
Palopegteriparatide (Yorvipath) (PDF)CP.PHAR.696December 1, 2025
Palovarotene (PDF)CP.PHAR.548October 1, 2025
Paltusotide (Palsonify) CP.PHAR.755December 1, 2025
Pancrelipase (Creon, Pancreaze, Pertyze, Viokace, Zenpep) (PDF)CP.PCH.44December 1, 2025
Panitumumab (Vectibix®) (PDF)CP.PHAR.321March 1, 2026
Panitumumab (Vectibix®) (PDF)CP.PHAR.321Version effective until March 1, 2026
Panobinostat (Farydak) (PDF)CP.PHAR.382September 1, 2024
Parathyroid Hormone (Natpara) (PDF)CP.PHAR.282April 1, 2025
Paricalcitol Injection (Zemplar) (PDF)CP.PHAR.270October 1, 2025
Pasireotide (Signifor LAR®) (PDF)CP.PHAR.332December 1, 2025
Patiromer (Veltassa) (PDF)CP.PMN.205October 1, 2025
Patisiran (Onpattro) (PDF)CP.PHAR.395July 1, 2025
Pazopanib (Votrient) (PDF)CP.PHAR.81December 1, 2025
Peanut allergen powder (Palforzia) (PDF)CP.PMN.220October 1, 2025
Pegaptanib (Macugen) (PDF)CP.PHAR.185May 1, 2023
Pegaspargase (Oncaspar), Calaspargase pegol-mknl (Asparlas) (PDF)CP.PHAR.353December 1, 2025
Pegcetacoplan (Empaveli0 (PDF)CP.PHAR.524December 1, 2025
Pegfilgrastim/Biosimilars, Eflapegrastim, Efbemalenograstim (PDF)CP.PHAR.296October 1, 2025
Peginterferon Alfa-2a (Pegasys) (PDF)CP.PHAR.89December 1, 2025
Peginterferon beta-1a (Plegridy) (PDF)CP.PHAR.271July 1, 2025
Pegloticase (Krystexxa) (PDF)CP.PHAR.115April 1, 2025
Pegunigalsidase Alfa (PRX-102) (PDF)CP.PHAR.512September 1, 2025
Pegvaliase-pqpz (Palynziq) (PDF)CP.PHAR.140March 1, 2026
Pegvaliase-pqpz (Palynziq) (PDF)CP.PHAR.140Version effective until March 1, 2026
Pegvisomant (Somavert) (PDF)CP.PHAR.389December 1, 2025
Pembrolizumab, Pembrolizumab Berahyaluronidase alfa-pmph (Keytruda, Keytruda Qlex) (PDF)CP.PHAR.322February 1, 2026
Pembrolizumab, Pembrolizumab Berahyaluronidase alfa-pmph (Keytruda, Keytruda Qlex) (PDF)CP.PHAR.322Version effective until February 1, 2026
Pemetrexed (Alimta, Pemfexy) (PDF)CP.PHAR.368December 1, 2025
Pemigatinib (Pemazyre) (PDF)CP.PHAR.496December 1, 2025
Penicillamine (Cuprimine) (PDF)CP.PCH.09December 1, 2025
 Penpulimab-kcqx (PDF)CP.PHAR.732October 1, 2025
Pentosan polysulfate sodium (Elmiron) (PDF)CP.PMN.276June 1, 2023
Perampanel (Fycompa) (PDF)CP.PMN.156January 1, 2026
Perampanel (Fycompa) (PDF)CP.PMN.156Version effective until January 1, 2026
Perfluorohexyloctane (Miebo) (PDF)CP.PMN.290October 1, 2025
Pertuzumab (Perjeta) (PDF)CP.PHAR.227January 1, 2026
Pertuzumab-trastuzumab-hyaluronidase-zzxf (Phesgo) (PDF)CP.PHAR.501October 1, 2025
Pexidartinib (Turalio)(PDF)CP.PHAR.436December 1, 2025
Phendimetrazine (PDF)CP.PCH.47July 1, 2025
Phentermine (Adipex-P, Lomaira) (PDF)CP.PCH.13July 1, 2025
Pilocarpine (Vuity) (PDF)CP.PMN.270March 1, 2026
Pilocarpine (Vuity) (PDF)CP.PMN.270Version effective until March 1, 2026
Pimavanserin (Nuplazid) (PDF)CP.PMN.140October 1, 2025
Pirfenidone (Esbriet) (PDF)CP.PHAR.286October 1, 2025
Pirtobrutinib (Jaypirca) (PDF)CP.PHAR.620July 1, 2025
Pitolisant (Wakix) (PDF)CP.PMN.221October 1, 2025
Plasminogen, Human-tvmh (Ryplazim) (PDF)CP.PHAR.513December 1, 2025
Plecanatide (Trulance) (PDF)CP.PMN.87January 1, 2025
Plerixafor (Mozobil) (PDF)CP.PHAR.323October 1, 2025
Polatuzumab Vedotin-piiq (Polivy) (PDF)CP.PHAR.433October 1, 2025
Pomalidomide (Pomalyst) (PDF)CP.PHAR.116March 1, 2026
Pomalidomide (Pomalyst) (PDF)CP.PHAR.116Version effective until March 1, 2026
Ponatinib (Iclusig) (PDF)CP.PHAR.112July 1, 2025
Ponesimod (Ponvory) (PDF)CP.PHAR.537October 1, 2025
Potassium (Klor-Con) (PDF)HIM.PA.143April 1, 2025
Pozelimab-bbfg (Veopoz) (PDF)CP.PHAR.626September 1, 2025
Prademagene Zamikeracel (EB-101) (PDF)CP.PHAR.609January 1, 202
Pralatrexate (Folotyn®) (PDF)CP.PHAR.313March 1, 2026
Pralatrexate (Folotyn®) (PDF)CP.PHAR.313Version effective until March 1, 2026
Pralsetinib (Gavreto) (PDF)CP.PHAR.514June 1, 2023
Pramlintide (Symlin) (PDF)CP.PMN.129April 1, 2025
Prasterone (Intrarosa) (PDF)CP.PMN.99December 1, 2025
Pregabalin (Lyrica, Lyrica CR) (PDF)CP.PMN.33January 1, 2026
Pregabalin (Lyrica, Lyrica CR) (PDF)CP.PMN.33Version effective until January 1, 2026
Pretomanid (PDF)CP.PMN.222April 1, 2025
Progesterone (Crinone, Endometrin, Milprosa) (PDF)CP.PMN.243October 1, 2025
Propranolol HCl Oral Solution (Hemangeol) (PDF)CP.PCH.51July 1, 2025
protein c concentrate, human (Ceprotin®) (PDF)CP.PHAR.330April 1, 2025
propranolol HCL solution (Hemangeol) (PDF)CP.PMN.58January 1, 2024
Prucalopride (Motegrity) (PDF)HIM.PA.159December 1, 2025
Pyrimethamine (Daraprim®) (PDF)CP.PMN.44October 1, 2025
Quantity Limit Override and Dose Optimization (PDF)CP.PMN.59March 1, 2026
Quantity Limit Override and Dose Optimization (PDF)CP.PMN.59Version effective until March 1, 2026
Quetiapine ER (Seroquel XR) (PDF)CP.PMN.64April 1, 2025
Quinine Sulfate (Qualaquin) (PDF)CP.PMN.262October 1, 2025
Quizartinib (Vanflyta) (PDF)CP.PHAR.646March 1, 2026
Quizartinib (Vanflyta) (PDF)CP.PHAR.646Version effective until March 1, 2026
Ramucirumab (Cyramza) (PDF)CP.PHAR.119July 1, 2025
Ranibizumab (Lucentis, Susvimo), Lucentis Biosimilars  (PDF)CP.PHAR.186August 1, 2025
Rasagiline (Azilect®) (PDF)HIM.PA.89October 1, 2025
Ravulizumab-cwvz (Ultomiris) (PDF)CP.PHAR.415December 1, 2025
Regorafenib (Stivarga) (PDF)CP.PHAR.107July 1, 2025
Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (PDF)CP.PHAR.529October 1, 2025
Remestemcel-L (Ryoncil) (PDF)CP.PHAR.474January 1, 2026
Remetirom (Rezdiffra) (PDF)CP.PHAR.647March 1, 2026
Remetirom (Rezdiffra) (PDF)CP.PHAR.647Version effective until March 1, 2026
Remibrutinib (Rhapsido)CP.PHAR.756December 1, 2025
Repository Corticotropin Injection (H.P. Acthar Gel) (PDF)CP.PHAR.168May 1, 2023
Repotrectinib (Augtyro) (PDF)CP.PHAR.667April 1, 2025
Respiratory Syncytial Virus Vaccine (Abrysvo) (PDF)CP.PHAR.658January 1, 2025
Reslizumab (Cinqair) (PDF)CP.PHAR.223April 1, 2025
Retifanlimab-dlwr (Zynyz) (PDF)CP.PHAR.629August 1, 2025
Revakinagene Taroretcel-lwey (Encelto) (PDF)CP.PHAR.697January 1, 2026
Revumenib (Revuforj) (PDF)CP.PHAR.707April 1, 2025
Ribavirin (Copegus, Moderiba, Rebetol, Ribasphere) (PDF)CP.PHAR.141December 1, 2025
Ribociclib (Kisqali, Kisqali Femara) (PDF)CP.PHAR.334December 1, 2025
Rifabutin (Mycobutin) (PDF)CP.PMN.223December 1, 2025
Rifamycin (Aemcolo) (PDF)CP.PMN.196October 1, 2025
Rifaximin (Xifaxan®) (PDF)CP.PMN.47December 1, 2025
Rilonacept (Arcalyst) (PDF)CP.PHAR.266September 1, 2025
Rilzabrutinib (Wayrilz) (PDF)CP.PHAR.751March 1, 2026
Ripretinib (Qinlock) (PDF)CP.PHAR.502October 1, 2025
RimabotulinumtoxinB (Myobloc) (PDF)CP.PHAR.233October 1, 2025
Rimegepant (Nurtec ODT) (PDF)CP.PHAR.490December 1, 2025
Riociguat (Adempas®) (PDF)CP.PHAR.195April 1, 2025
Risdiplam (Evrysdi) (PDF)CP.PHAR.477July 1, 2025
Risedronate (Actonel, Atelvia) (PDF)CP.PMN.100December 1, 2025
Risperidone Long-Acting Injection (Risperdal Consta) (PDF)CP.PHAR.293December 1, 2025
Rituximab (Rituxan, Riabni, Ruxience, Truxima, Rituxan Hycela) (PDF)CP.PHAR.260March 1, 2026
Rituximab (Rituxan, Riabni, Ruxience, Truxima, Rituxan Hycela) (PDF)CP.PHAR.260Version effective until March 1, 2026
Roflumilast (Daliresp, Zoryve) (PDF)CP.PMN.46December 1, 2025
Rolapitant (Varubi) (PDF)CP.PMN.102October 1, 2025
Romidepsin (Istodax®) (PDF)CP.PHAR.314December 1, 2025
Romiplostim (Nplate®) (PDF)CP.PHAR.179January 1, 2026
Romiplostim (Nplate®) (PDF)CP.PHAR.179Version effective until January 1, 2026
Romosozumab-aqqg (Evenity) (PDF)CP.PHAR.428December 1, 2025
Ropeginterferon alfa-2b-njft (Besremi) (PDF)CP.PHAR.570April 1, 2025
Rozanolixizumab-noli (Rystiggo) (PDF)CP.PHAR.648March 1, 2026
Rozanolixizumab-noli (Rystiggo) (PDF)CP.PHAR.648Version effective until March 1, 2026
RP-L201 (PDF)CP.PHAR.599December 1, 2023
Rucaparib (Rubraca®) (PDF)CP.PHAR.350April 1, 2025
Rufinamide (Banzel) (PDF)CP.PMN.157December 1, 2025
Ruxolitinib (Jakafi) (PDF)CP.PHAR.98February 1, 2026
Ruxolitinib (Jakafi) (PDF)CP.PHAR.98Version effective until February 1, 2026
Sacituzumab Govitecan-hziy (Trodelvy) (PDF)CP.PHAR.475July 1, 2025
Sacubitril/Valsartan (Entresto) (PDF)CP.PCH.52Retire by March 1, 2026
Safinamide (Xadago) (PDF)CP.PMN.113April 1, 2025
Sapropterin Dihydrochloride (Kuvan, Javygtor) (PDF)CP.PHAR.43March 1, 2026
Sapropterin Dihydrochloride (Kuvan, Javygtor) (PDF)CP.PHAR.43Version effective until March 1, 2026
Sarecycline (Seysara) (PDF)CP.PMN.189April 1, 2025
Sargramostim (Leukine) (PDF)CP.PHAR.295December 1, 2025
Satralizumab-mwge (Enspryng) (PDF)CP.PHAR.463December 1, 2025
Sebelipase Alfa (Kanuma) (PDF)CP.PHAR.159July 1, 2025
 Sebetralstat (Ekterly) (PDF)CP.PHAR.723November 1, 2025
Secnidazole (Solosec) (PDF)CP.PMN.103April 1, 2025
Seladelpar (Livdelzi) (PDF)CP.PHAR.698December 1, 2025
Selexipag (Uptravi®) (PDF)CP.PHAR.196April 1, 2025
Selinexor (Xpovio) (PDF)CP.PHAR.431October 1, 2025
Selpercatinib (Retevmo) (PDF)CP.PHAR.478July 1, 2025
Selumetinib (Koselugo) (PDF)CP.PHAR.464February 1, 2026
Selumetinib (Koselugo) (PDF)CP.PHAR.464Version effective until February 1, 2026
Semaglutide (Wegovy) (PDF)CP.PMN.295March 1, 2026
Semaglutide (Wegovy) (PDF)CP.PMN.295Version effective until March 1, 2026
Sepiapterin (Sephience) (PDF)CP.PHAR.708November 1, 2025
Setmelanotide (Imcivree) (PDF)CP.PHAR.491July 1, 2025
Short ragweed pollen allergen extract (Ragwitek) (PDF)CP.PMN.83October 1, 2025
Sildenafil (Revatio®) (PDF)CP.PHAR.197April 1, 2025
Sildenafil (Viagra) (PDF)CP.PCH.07July 1, 2025
Siponimod (Mayzent) (PDF)CP.PHAR.427October 1, 2025
Sipuleucel-T (Provenge) (PDF)CP.PHAR.120June 1, 2024
Sirolimus Protein-Bound Particles (Fyarro), topical gel (Hyftor) (PDF)CP.PHAR.574April 1, 2025
Siltuximab (Sylvant) (PDF)CP.PHAR.329April 1, 2025
Sodium Oxybate (Xyrem, Lumryz) and Calcium Magnesium Potassium Sodium Oxybate (Xywav) (PDF)CP.PMN.42October 1, 2025
Sodium-Glucose Co-Transporter 2 Inhibitors (PDF)HIM.PA.91January 1, 2026
Sodium-Glucose Co-Transporter 2 Inhibitors (PDF)HIM.PA.91Version effective until January 1, 2026
Sodium Phenylbutyrate (Buphenyl) (PDF)CP.PHAR.208April 1, 2025
Sodium Phenylbutyrate/Taurursodiol (Relyvrio) (PDF)CP.PHAR.584July 1, 2025
Sodium thiosulfate (Pedmark) (PDF)CP.PHAR.610April 1, 2025
Sodium Zirconium Cyclosilicate (Lokelma) (PDF)CP.PMN.163October 1, 2025
Sofosbuvir-Velpatasvir (Epclusa) (PDF)HIM.PA.SP1December 1, 2025
Sofosbuvir (Sovaldi) (PDF)HIM.PA.SP2December 1, 2025
Sofosbuvir-Vepatasvir-Voxilaprevir (Vosevi) (PDF)HIM.PA.SP63December 1, 2025
Solriamfetol (Sunosi) (PDF)CP.PMN.209September 1, 2025
Sonidegib (Odomzo) (PDF)CP.PHAR.272July 1, 2025
Sorafenib (Nexavar) (PDF)CP.PHAR.69September 1, 2025
Sotatercept (ACE-011) (PDF)CP.PHAR.657April 1, 2025
Sotorasib (Lumakras) (PDF)CP.PHAR.549October 1, 2025
Sotrovimab (VIR-7831) (PDF)CP.PHAR.541Pending FDA Approval
Sparsentan (Filspari) (PDF)CP.PHAR.631October 1, 2025
Spesolimab-sbzo (Spevigo) (PDF)CP.PHAR.606October 1, 2025
Spinosad (Natroba) (PDF)HIM.PA.134September 1, 2024
Step Therapy Criteria (PDF)HIM.PA.109January 1, 2026
Step Therapy Criteria (PDF)HIM.PA.109Version effective until January 1, 2026
Stiripentol (Diacomit) (PDF)CP.PMN.184December 1, 2025
Sunitinib (Sutent) (PDF)CP.PHAR.73September 1, 2025
 Sunvozertinib (Zegfrovy) (PDF)CP.PHAR.742October 1, 2025
Sutimlimab-jome (Enjaymo) (PDF)CP.PHAR.503July 1, 2025
Suvorexant (Belsomra®) (PDF)CP.PMN.109December 1, 2025
Suzetrigine (Journavx)  (PDF)CP.PMN.301October 1, 2025
Tadalafil (Adcirca®) (PDF)CP.PHAR.198April 1, 2025
Tadalafil BHP - ED (Cialis) (PDF)CP.PMN.132October 1, 2025
Tafamidis (Vyndaqel, Vyndamax) (PDF)CP.PHAR.432October 1, 2025
Tafasitamab-cxix (Monjuvi) (PDF)CP.PHAR.508December 1, 2025
Talquetamab-tgvs (Talvey) (PDF)CP.PHAR.649March 1, 2026
Talquetamab-tgvs (Talvey) (PDF)CP.PHAR.649Version effective until March 1, 2026
Talazoparib (Talzenna) (PDF)CP.PHAR.409April 1, 2025
Taletrectinib (Ibtrozi) (PDF)CP.PHAR.741October 1, 2025
Taliglucerase Alfa (Elelyso) (PDF)CP.PHAR.157October 1, 2025
Talimogene laherparepvec (Imlygic) (PDF)CP.PHAR.542October 1, 2025
Tapinarof (Vtama) (PDF)CP.PMN.283December 1, 2025
Tarlatamab-dlle (Imdelltra) (PDF)CP.PHAR.685January 1, 2026
Tasimelteon (Hetlioz) (PDF)CP.PMN.104December 1, 2025
Tavaborole (Kerydin®) (PDF)CP.PMN.105April 1, 2025
Tazarotene (Arazlo, Fabior, Tazorac) (PDF)CP.PMN.244December 1, 2025
Tazemetostat (PDF)CP.PHAR.452April 1, 2025
Tebentafusp-tebn (Kimmtrak) (PDF)CP.PHAR.575July 1, 2025
Teclistamab-cqyv (Tecvayli) (PDF)CP.PHAR.611April 1, 2025
Tedizolid (Sivextro) (PDF)CP.PMN.62October 1, 2025
Teduglutide (Gattex) (PDF)CP.PHAR.114April 1, 2025
 Telisotuzumab Vedotin-tllv (Emrelis) (PDF)CP.PHAR.733November 1, 2025
Telotristat ethyl (Xermelo) (PDF)CP.PHAR.337October 1, 2025
Temozolomide (Temodar) (PDF)CP.PHAR.77September 1, 2025
Temsirolimus (Torisel®) (PDF)CP.PHAR.324December 1, 2025
Tenapanor (Ibsrela, Xphozah) (PDF)HIM.PA.174July 1, 2025
Tenapanor (Ibsrela, Xphozah)CP.PMN.224October 1, 2025
Tenofovir Alafenamide Fumarate (Vemlidy) (PDF)CP.PMN.268December 1, 2025
Teplizumab (PDF)CP.PHAR.492April 1, 2025
Tepotinib (Tepmetko) (PDF)CP.PHAR.530July 1, 2025
Teprotumumab (Tepezza) (PDF)CP.PHAR.465December 1, 2025
Teriflunomide (Aubagio) (PDF)CP.PCH.40July 1, 2025
Teriparatide (Forteo®) (PDF)CP.PHAR.188October 1, 2025
Tesamorelin (Egrifta) (PDF)CP.PHAR.109October 1, 2025
Testosterone (Androderm) (PDF)HIM.PA.87December 1, 2025
Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF)CP.PHAR.354December 1, 2025
Tetrabenazine (Xenazine) (PDF)CP.PHAR.92July 1, 2025
Tezacaftor-Ivacaftor (Symdeko) (PDF)CP.PHAR.377December 1, 2025
Tezepelumab (Tezspire) (PDF)HIM.PA.176March 1, 2026
Tezepelumab (Tezspire) (PDF)CP.PHAR.576Retire by March 1, 2026
Thalidomide (Thalomid) (PDF)CP.PHAR.78October 1, 2025
Thioguanine (Tabloid) (PDF)CP.PHAR.437March 1, 2026
Thioguanine (Tabloid) (PDF)CP.PHAR.437Version effective until March 1, 2026
Thyrotropin Alfa (Thyrogen) (PDF)CP.PHAR.95October 1, 2025
Timothy grass pollen allergen extract (Grastek®) (PDF)CP.PMN.84October 1, 2025
Tiopronin Delayed-Release (Thiola EC) (PDF)CP.PCH.50July 1, 2025
Tiopronin Delayed-Release (Thiola EC) (PDF) CP.PHAR.725January 1, 2026
Tiopronin Delayed-Release (Thiola EC) (PDF) CP.PHAR.725Version effective until January 1, 2026
Tirzepatide (Zepbound) (PDF)CP.PMN.298March 1, 2026
Tirzepatide (Zepbound) (PDF)CP.PMN.298Version effective until March 1, 2026
Tisagenlecleucel (Kymriah) (PDF)CP.PHAR.361January 1, 2026
Tislelizumab-jsgr (Tevimbra) (PDF)CP.PHAR.687October 1, 2025
Tisotumab Vedotin-tftv (Tivdak) (PDF)CP.PHAR.561March 1, 2026
Tisotumab Vedotin-tftv (Tivdak) (PDF)CP.PHAR.561Version effective until March 1, 2026
Tivozanib (Fotivda) (PDF)CP.PHAR.538July 1, 2025
Tixagevimab-Cilgavimab (Evusheld) (PDF)CP.PHAR.571July 1, 2023
Tobramycin (PDF)CP.PHAR.211October 1, 2025
Tocilizumab
(Actemra), Tocilizumab-bavi (Tofidence), Tocilizumab-aazg (Tyenne)(PDF)
CP.PHAR.263January 1, 2025
Tofersen (Qalsody) (PDF)CP.PHAR.591March 1, 2026
Tofersen (Qalsody) (PDF)CP.PHAR.591Version effective until March 1, 2026
Tolvaptan (Jynarque) (PDF)CP.PHAR.27December 1, 2025
Topotecan (Hycamtin) (PDF)CP.PHAR.64July 1, 2025
Topical Acne Treatment (PDF)HIM.PA.71December 1, 2025
Topical Immunomodulators (PDF)CP.PMN.107April 1, 2025
Topiramate ER (Qudexy XR, Trokendi XR (PDF)CP.PMN.281October 1, 2025
Toripalimab-tpzi (Loqtorzi) (PDF)CP.PHAR.668April 1, 2025
Tovorafenib (Ojemda) (PDF)CP.PHAR.686October 1, 2025
Trabectedin (Yondelis) (PDF)CP.PHAR.204April 1, 2025
Tralokinumab-ldrm (Adbry) (PDF)CP.PCH.60March 1, 2026
Tralokinumab-ldrm (Adbry) (PDF)CP.PHAR.577Retire by March 1, 2026
Trametinib (Mekinist) (PDF)CP.PHAR.240July 1, 2025
Trastuzumab Biosimilars Trastuzumab-Hyaluronidase (PDF)CP.PHAR.228August 1, 2025
Travoprost (iDose TR) (PDF)CP.PHAR.672April 1, 2025
Tremelimumab-actl (Imjudo) (PDF)CP.PHAR.612June 1, 2025
Tremelimumab-actl (Imjudo) (PDF)CP.PHAR.612June 1, 2025
Treprostinil (Orenitram, Remodulin, Tyvaso, Yutrepia)  (PDF)CP.PHAR.199November 1, 2025
Triamcinolone ER Injection (Zilretta) (PDF)CP.PHAR.371December 1, 2025
Triclabendazole (Egaten) (PDF)CP.PMN.207October 1, 2025
Trientine (Syprine) (PDF)CP.PHAR.438March 1, 2026
Trientine (Syprine) (PDF)CP.PHAR.438Version effective until March 1, 2026
Trifarotene (Aklief) (PDF)CP.PMN.225April 1, 2025
Trifluridine/Tipiracil (Lonsurf) (PDF)CP.PHAR.383October 1, 2025
Triheptanoin (Dojolvi) ^ (PDF)CP.PHAR.509December 1, 2025
Triptorelin pamoate (Trelstar®, Triptodur®) (PDF)CP.PHAR.175March 1, 2026
Triptorelin pamoate (Trelstar®, Triptodur®) (PDF)CP.PHAR.175Version effective until March 1, 2026
Trofinetide (Daybue) (PDF)CP.PHAR.600July 1, 2025
Tucatinib (Tukysa) (PDF)CP.PHAR.497October 1, 2025
Ublituximab-xiiy (Briumvi) (PDF)CP.PHAR.621October 1, 2025
Udenafil (PDF)CP.PHAR.557December 1, 2023
Ulcer Therapy Combinations (Omeclamox Pak, Pylera, Talicia)(PDF)CP.PMN.277October 1, 2025
Umbralisib (Ukoniq) (PDF)CP.PHAR.531July 1, 2025
Uridine acetate (Vistogard) (PDF)HIM.PA.SP55December 1, 2025
Vadadustat (Vafseo) (PDF)CP.PHAR.677September 1, 2025
Valbenazine (Ingrezza, Ingrezza Sprinkle) (PDF)CP.PHAR.340January 1, 2026
Valbenazine (Ingrezza, Ingrezza Sprinkle) (PDF)CP.PCH.48Retire by January 1, 2026
valganciclovir (Valcyte) (PDF)CP.PCH.06April 1, 2025
Valoctocogene Roxaparvovec (PDF)CP.PHAR.466January 1, 2026
Valrubicin (Valstar) (PDF)CP.PHAR.439March 1, 2026
Valrubicin (Valstar) (PDF)CP.PHAR.439Version effective until March 1, 2026
Vamorolone (Agamree) (PDF)CP.PHAR.659April 1, 2025
Vandetanib (Caprelsa®) (PDF)CP.PHAR.80April 1, 2025
Vanzacaftor/Tezacaftor/Deutivacaftor (Alyftrek)  (PDF)CP.PHAR.700December 1, 2025
Varenicline (Tyrvaya) (PDF)CP.PMN.273April 1, 2025
Velaglucerase Alfa (VPRIV) (PDF)CP.PHAR.163October 1, 2025
Velmanase Alfa-tycv (Lamzede) (PDF)CP.PHAR.601July 1, 2025
Vemurafenib (Zelboraf®) (PDF)CP.PHAR.91June 1, 2025
Venetoclax (Venclexta) (PDF)CP.PHAR.129March 1, 2026
Venetoclax (Venclexta) (PDF)CP.PHAR.129Version effective until March 1, 2026
Vestronidase alfa-vjbk (Mepsevii) (PDF)CP.PHAR.374July 1, 2025
Verteporfin (PDF)CP.PHAR.187April 1, 2025
Vigabatrin (Sabril) (PDF)CP.PHAR.169September 1, 2024
Viloxazine (Qelbree) (PDF)CP.PMN.264November 1, 2025
Viltolarsen (Viltepso) (PDF)CP.PHAR.484April 1, 2025
Vimseltinib (Romvimza) (PDF)CP.PHAR.726July 1, 2025
Vismodegib (Erivedge) (PDF)CP.PHAR.273July 1, 2025
Vutrisiran (Amvuttra)CP.PHAR.550July 1, 2025
Voclosporin (Lupkynis) (PDF)CP.PHAR.504July 1, 2025
Vorapaxar (Zontivity) (PDF)HIM.PA.146April 1, 2025
Vorasidenib (Voranigo) (PDF)CP.PHAR.699March 1, 2026
Vorasidenib (Voranigo) (PDF)CP.PHAR.699Version effective until March 1, 2026
Voretigene neparvovec-rzyl (Luxturna) (PDF)CP.PHAR.372January 1, 2026
Vorinostat (Zolinza) (PDF)CP.PHAR.83October 1, 2025
Vortioxetine (Trintellix®) (PDF)CP.PMN.65October 1, 2025
Vosoritide (Voxzogo) (PDF)CP.PHAR.525April 1, 2025
Voxelotor (Oxbryta) (PDF)CP.PHAR.451April 1, 2025
Xanomeline-trospium chloride (Cobenfy) (PDF)CP.PMN.299April 1, 2025
Zanidatamab-hrii (Ziihera) (PDF)CP.PHAR.709August 1, 2025
Zanubrutinib (Brukinsa) (PDF)CP.PHAR.467October 1, 2025
Zavegepant (Zavzpret) (PDF)CP.PHAR.630December 1, 2025
Zenocutuzumab-zbco (Bizengri) (PDF)CP.PHAR.713August 1, 2025
Zilucoplan (RA101495) (PDF)CP.PHAR.616June 1, 2025
Ziv-aflibercept (Zaltrap®) (PDF)CP.PHAR.325December 1, 2025
Zolbetuximab-clzb (Vyloy) (PDF)CP.PHAR.705March 1, 2026
Zolbetuximab-clzb (Vyloy) (PDF)CP.PHAR.705Version effective until March 1, 2026
Zoledronic acid (PDF)CP.PHAR.59December 1, 2025
Zongertinib (Hernexeos) (PDF)CP.PHAR.750March 1, 2026
Zopapogene Imadenovec (Papzimeos) (PDF)CP.PHAR.730March 1, 2026
Zuranolone (Zurzuvae) (PDF)CP.PHAR.650 July 1, 2025